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AN EXAMINATION OF THE INFLUENCE OF SOCIOECONOMIC STATUS AND 
RACE ON END-OF-LIFE TREATMENT LEVEL FOLLOWING A PALLIATIVE 
INTERVENTION 
 
by 
 
KATHLEEN BENTON  
 
(Under the Direction of James Stephens) 
ABSTRACT 
The purpose of this study was to examine differences in treatment level at the end 
of life according to race and socioeconomic status and the extent a palliative intervention 
may change the course and cost of care. The study population included patients from the 
Medical Center of Central Georgia (N=2,920). The data were examined as a secondary 
analysis retrospectively. Data from the medical record and a unique clinical database 
were coded into descriptive, predictor, and outcome variables to define the population, 
and the patient’s treatment status before and after the intervention.  McNemar’s test of 
symmetry, Chi Square, and Logistic Regression models were used to examine 
relationships between predictor and outcome variables including race, gender, age, 
disease, income, and education levels affecting code status, comfort status and discharge 
to hospice. Costs pre- and post-intervention were also examined using the t-test. Results 
demonstrated that the palliative intervention had a significant effect on costs and care 
level. Further, African Americans with lower levels of education were more likely to 
choose aggressive measures than Caucasians. Findings may improve understanding of the 
palliative intervention and encourage culturally competent end-of-life education. 
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CHAPTER 1 
INTRODUCTION 
Background 
The economics of death, including high healthcare costs at the end of life, are well 
documented (Zhang et al., 2009).  However, no appropriate value for spending at the end 
of life is known. Historical trends for end-of-life spending document the particularly high 
costs associated with care in the last year of life (Emanuel & Emanuel, 1994; Luce & 
Rubenfield, 2002).  According to Reynolds, Cooper, and McKneally (2005), many issues 
contribute to this dilemma. Glass and Nahapetyan (2008) believe that it is attributable to 
America’s “death denying culture” (p. 4).  Others argue that because heightened 
technology has become so effective at extending life, it becomes more difficult to 
recognize what defines end of life (Reynolds et al., 2005).  Though the United States 
medical system allows for continued aggressive care for the dying, disparities still exist 
in basic primary care; and in comparison with other countries, America still views 
mortality as a choice (Lown, 1998).  
Fr. Thomas Nairn (2009) wrote that there are few professionals who are willing to 
provide comprehensive end-of-life guidance.  The Patient Self Determination Act of 1991 
increased the autonomy of the patient and proposed the use of advance care planning 
documents to motivate end-of-life discussions (Grimaldo, et al., 2001).  Yet, many 
healthcare providers in America still have not reached the point where they are ready to 
lead these difficult discussions, at least not until they become forced to do so (Nairn, 
2009).   
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In 2010, The New Yorker published a case study that centered on a young female 
patient who was diagnosed with lung cancer shortly before she delivered her first child.  
Her physician wrote about the final three months of this woman’s life, which included 
four rounds of chemotherapy and countless tests and hospital visits.  Similar to other case 
studies on patients and their end of life (Srivasta, 2007), this woman’s life ended in a 
hospital bed against her wishes to die peacefully at home – a consequence of the medical 
world’s inability to ease her into the dying process (Gawande, 2010).  For a patient with a 
fatal disease, the aggressive treatments and utilization of expensive resources at the end 
of life may include “three-thousand-dollar-a-day intensive care, five-thousand-dollar-an-
hour surgery.  But, ultimately death comes...” (Gawande, 2010, p. 3).  
Palliative care includes interdisciplinary symptom management with the goal of 
improved quality of life through the use of clinical, emotional, psychosocial, and spiritual 
triggers (Griffin, Koch, Nelson, & Cooley, 2007).  A variety of palliative models have 
been utilized and published (Babcock & Robinson, 2011; Crawford & Price, 2003; Curtis 
& Rubenfield, 2005; Nelson et al., 2010; Spugnardi, 2008).   One aspect of the palliative 
discipline is the ability of the trained healthcare professional to engage in a meaningful 
discussion about patient feelings on quality of life and wishes for the end of life.  
Palliative care is not Hospice. Hospice care is defined as end-of-life care exclusively, 
with no aggressive measures (National Hospice and Palliative Care Organization 
(NHPCO), 2009). Palliative care can include management of symptoms at the same time 
that the patient is receiving aggressive treatment for the underlying condition (Griffin et 
al., 2007). 
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Research documents consistent differences on end-of-life treatment preferences 
according to race, and more recently studies have included socioeconomic status as a 
predictor for these same decisions (Muni, Engelberg, Treece, Dotolo, & Curtis, 2011).  
African American patients are more likely to choose aggressive care at the end of life, 
even though their use of medical interventions at disease diagnosis is less common 
(Johnson et. al, 2010).  Efforts to address potentially inappropriate and burdensome 
aggressive care decisions for all populations have been made through the work of the 
palliative care and hospice movements (e.g., Center to Advance Palliative Care (CAPC), 
2009; NHPCO, 2009).   
The literature includes an abundance of studies indicating that the use of a 
palliative intervention results in cost savings for the system, as well as quicker de-
escalation, meaning a shift in care from high level aggressive measures like artificial 
supports and therapeutic medications to pain control and withdrawal of support (Appleby, 
2006; Emanuel & Emanuel, 1994; Hansen, Usher, Spragens, & Bernard, 2008; Meier & 
Beresford, 2008; Zhang et al., 2009).  De-escalation may include changes to care such as 
Do Not Resuscitate, or DNR orders, withdrawal of care decisions, and hospice 
discharges. Through the use of successful palliative care models, effective and 
appropriate comfort measures also lead to healthcare resource savings, while providing 
enhanced quality and support to patients and their families at a critical time (Meier & 
Beresford, 2008).  
Purpose of the Study 
The purpose of this study was to examine differences in treatment level at the end 
of life according to socioeconomic status and race.  Data included treatment level 
   
4 
 
measurements before and after the palliative intervention using a secondary data set.  
Length of stay costs aligned with treatment level was also examined relative to 
socioeconomic status and race.  
The Transitions Palliative Care Model is a counseling-initiated palliative model 
used at the Medical Center of Central Georgia in Macon, (MCCG).  This study used pre-
existing retrospective quantitative data collected by the program to examine code status, 
care level shift to comfort measures only, hospice decisions, and costs associated with 
care level and length of stay before and after the palliative intervention.   
Significance of the Study 
This study adds to the literature in two distinct ways.  First, while there is a 
growing body of literature on race and ethnic disparities in healthcare, few studies 
address racial disparities specific to the end of life (Bach, Cramer, Warren, & Begg, 
1999; Barnato et al., 2006; Borum, Lynn, & Zhong, 2000; Degenholtz, Thomas, & 
Miller, 2003; Epstein & Ayanian, 2001; Muni et al.,). Second, few studies address 
socioeconomic status as a confounder to racial differences in care choice (Muni et al., 
2011; Fiscella & Franks, 2001; Fowler et al., 2010; Franks & Fiscella, 2002; Muni, et al., 
2011). This research addressed both areas of disparity in public health.   
Two measures of effective public health practice include improved quality of life 
and more efficient allocation of resources (Teitelbaum & Wilensky, 2009).  Healthcare 
spending constitutes 17% of the Gross Domestic Product, and this is far greater than any 
other expenditure in the US, including national defense (Finkler, 2005).  President Barack 
Obama initially pledged $675 billion towards healthcare reform in 2009. This figure 
remains ever-increasing.  President Obama has asked hospitals, physicians and 
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administrators to stand by their pledge to be more efficient with healthcare dollars in their 
medical practices (Inglehart, 2009).  The significance of end-of-life care on healthcare 
costs is evident throughout the literature (Appleby, 2006; Emanuel & Emanuel, 1994; 
Hansen, et al., 2008; Meier & Beresford, 2008; Zhang et al., 2009). 
Healthcare resources spent at the end of life are well documented, with care in the 
last week of life accounting for higher costs and poorer quality end-of-life experience 
when end-of-life discussions have not taken place (Zhang et.al, 2009). When end-of-life 
discussions do not occur, futile aggressive care continues and a prolonged death with 
poor quality and high costs may result (Glass & Nahapetyan, 2008).  Participant 
physicians in one study asserted that this type of conversation is not in their training, and 
that the importance of their role is curing and healing, not discussing “unimportant” side 
effects (Hordern & Street, 2007).  However, beyond the quality of subsequent death is the 
concern for what quality of life will accompany the progression of a disease.  A Palliative 
care team has been proven to be more effective than other professionals in healthcare at 
leading discussions about quality of life and end-of-life care options (Fineberg, 2005).  
After all information is shared and communication barriers are addressed, patients and 
families may continue to choose artificial support. Some patient values may align with 
this quality of end of life.  However, the success of the intervention is the ability to 
inform and educate (Babcock & Robinson, 2010). 
Millions of people each year are diagnosed with terminal illness and may benefit 
from palliative measures to improve quality of life outcomes. Furthermore, issues of 
quality of life during illness are critical to overall public health practice (Adunsky, 
Aminoff, Bechor, Arad, & Bercovitch, 2008).  Psychological and physiological distress, 
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produced by a patient’s inability to cope with the adverse events from disease and 
treatment, affects the magnitude of poor quality of life (Lethborg, Aranda, Cox & 
Kissane, 2007).   
Definition of Terms 
The following are terms used throughout this research and are relevant to the 
purpose and significance of the study. This section provides definitions to ensure that the 
reader is familiar with key terms used in this dissertation paper. 
Advance Directive. Advance Directives allow a patient to have their wishes 
upheld at end of life when they cannot speak for themselves. They include both the living 
will and the durable power of attorney for healthcare (Tierny et al., 2001).     
Code Status.  For the purpose of this research, Code Status will reference the care 
status levels described below including DNR or Do Not Resuscitate, full code, and Status 
IV comfort measures. 
Consult. A consult is defined for the purpose of this research as a referral made from 
one physician service to another program or service. It is a formal request to assess a 
patient. 
De-escalation of Care. For the purpose of this research, De-escalation of Care is 
defined as any downward level treatment changes including Do Not Resuscitate, or DNR 
orders, withdrawal of care decisions, and hospice discharges.  
DNR.  DNR is the acronym for Do Not Resuscitate. This is an order written by a 
licensed physician and with consent from a patient or authorized party in reference to 
code status. The DNR code status, also Status II-Status IV at MCCG means there will be 
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no emergency treatment when a cardiac or respiratory arrest occurs. (Medical Center of 
Central Georgia, 2007).  
End-of-life Care. End-of-life Care is defined in this paper as care for the terminally ill 
patient. 
Full Code.  Full Code is defined as no DNR order in place and all emergency 
treatment given in the event of a cardiac or respiratory arrest. Full code also means full 
resuscitation or CPR, cardio-pulmonary resuscitation. Resuscitation is a combination of 
medicines and machines utilized to re-start respirations and the heart (Medical Center of 
Central Georgia, 2007). 
Hospice. Hospice care is defined as end-of-life care exclusively, with no aggressive 
measures aimed at curative results (NHPCO, 2009). 
Length of Stay. Length of Stay (LOS) is another tool to determine resources saved. 
Decreasing LOS may include overall hospital stay or proof of decreasing stay in a 
medical intensive care unit (Norton et al., 2007).   
MCCG.  The Medical Center of Central Georgia, Macon, GA. For the purpose of this 
research MCCG will be used to reference the entity where data collection and treatment 
was conducted. 
Palliative Care. Palliative care includes interdisciplinary symptom management with 
the goal of improved quality of life through the use of clinical, emotional, psychosocial, 
and spiritual triggers. This care is not mutually exclusive to aggressive measures (Griffin 
et al., 2007). 
Palliative Care Model.  Palliative Care Models are defined as those which include the 
interdisciplinary team of physician, nurse, social worker, spiritual counselor, volunteer 
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and pharmacist. This team works together to share “a philosophy of care and an 
organized, highly structured system…” (Crawford, 2011, p.13).  For this research, a 
palliative program is interchangeable with palliative model. 
Palliative Care Team.  Palliative care is a multidisciplinary approach to the relief of 
symptoms and suffering and the improvement of overall quality of life during illness. The 
Palliative Care Team is made up of all disciplines involved in this goal.  Palliative care 
team consultation includes a discussion surrounding long term goals of the patient/family 
including advance care planning and/or care at the end of life. The care team is patient 
and family centered (Griffin et al., 2007).  
Race. Race will include Caucasian (White) and African American (Black) patients 
only. For the purpose of this research, race is determined based on scripted questions 
asked at registration for MCCG patients in which patients self report their personal racial 
association. Race is not under the auspices of ethnicity for this research. 
Socioeconomic Status. Income and education will define a patient’s Socioeconomic 
Status (SES) based on the census tract that correlates with the patient’s address.  For the 
purpose of this research, SES is determined by address using a geocoding method 
described in the methodology section of this paper. 
Status One.  For the purpose of this research, Status One is defined by MCCG as 
complete care, no restrictions. The patient will receive all necessary medical care 
including CPR, full code (Medical Center of Central Georgia, 2007). This is also 
referenced as aggressive care throughout this paper. 
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Status Two.  For the purpose of this research, Status Two will not be included but is 
defined by MCCG as complete care, no CPR in cardiac/respiratory arrest (Medical 
Center of Central Georgia, 2007). 
Status Three.  For the purpose of this research, Status Three will not be included but 
is defined by MCCG as care and comfort plus other therapies agreed upon by authorized 
party and physician (Center for Palliative care, MCCG, Resuscitation Policy, 2007). 
Status Four.  For the purpose of this research, Status Four is defined by MCCG as no 
CPR, care and comfort only. This paper will also define the care as comfort measures 
only (Center for Palliative Care MCCG, Resuscitation Policy, 2007).  
Literature Review 
In 2007, The New England Journal of Medicine published a case study which 
explained some of the issues surrounding end-of-life care decisions.  The patient was a 
young married man with three small children.  When his cough started, his doctors did 
not think the case was serious, and thus he was prescribed a series of antibiotics 
(Srivastava, 2007).   
It was not until lab work showed an iron deficiency that the physicians confirmed 
a terminal diagnosis and doctors prescribed aggressive care.  The patient’s wife focused 
on each life-prolonging treatment measure, while the patient slowly realized his own 
demise was imminent (Srivastava, 2007).  
Each new round of physicians offered options, all of which excluded the reality of 
the patient’s impending death.  Though the diagnosis was clearly terminal, the patient 
was never discharged from the hospital nor offered choices of symptom management or 
end-of-life care.  Instead, the healthcare specialists kept him in the hospital for additional 
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tests. On the day before he died, an order was written for a liver biopsy.  Specialists 
planned to investigate his liver failure instead of addressing the end of his life – then 
suddenly, it was over.  Everyone, including the experts, seemed shocked – they never let 
him know; they never let him go (Srivastava, 2007). 
This study will investigate the end-of-life choices patients make at MCCG. Unlike 
the case presented above, this study’s patients will have had a palliative intervention prior 
to death. The purpose of this study is to examine if there are differences in treatment level 
at the end of life based on socioeconomic status and race. Data will include treatment 
level measurements before and after the palliative intervention.  The Transitions model is 
a counseling-based palliative model used at MCCG.  This study will utilize pre-existing 
retrospective quantitative data collected by this program to examine code status, 
withdrawal of care, and hospice decisions.  Furthermore, the study will look at potential 
cost savings and length of stay following a palliative consult. 
Palliative Care 
There is some misunderstanding and lack of acceptance surrounding the palliative 
discipline in healthcare.  Because death and end of life may be viewed as a “therapeutic 
failure” by physicians, the end-of-life stigma creates a barrier to the success of palliative 
programs (Baider & Wein, 2001, p. 98).  Palliative care is a multidisciplinary approach to 
the relief of symptoms and suffering, and its goal is the improvement of overall quality of 
life during illness.  Palliative care does not require that death be imminent, and such care 
may include aggressive treatment of the underlying diseases as well as pain and symptom 
management.  Palliative care is patient- and family-centered, and it includes discussions 
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surrounding the patient’s long term goals, including advance care planning and/or care at 
the end of life (Griffin et al., 2007).  
Palliative programs have been developed to meet the pain and symptom 
management needs of the populations with disease, and to help families and patients 
understand their therapeutic options (Gade et al., 2008). Palliative care as a discipline is 
relatively new. A significant SUPPORT study on communication at end of life took place 
prior to the palliative movement, and the study’s failure highlights the need for the 
palliative discipline (Knaus et al., 1995).  
The SUPPORT phase I prospective observational study and phase II randomized 
control trial was conducted in the early 1990s with a goal of improving communication in 
end-of-life care and reducing deaths on life-sustaining support. Five well-accredited 
academic hospitals participated over a two-year time period. Participants included 9,105 
adults hospitalized with a life-threatening disease (Knaus et al., 1995).  In the phase I 
portion of the study, poor communication was observed to highlight the breakdown in 
care goals between the physician and patient at the end of life. In the phase II 
intervention, communication was enhanced and information was heightened to physicians 
and patients through the work of trained SUPPORT nurses. Results from the study 
yielded no improvement in communication breakdown or decrease in prolonged deaths 
through the use of life-sustaining therapies. The study authors speculated that the failure 
of the intervention proved the ongoing need for consistent interventions to discuss 
advance care planning and goals of care. Without name, it highlighted the need for 
palliative care in hospitals. This study holds historical significance as credible research 
evidencing the need for palliative care interventions (Knaus, 1995).  
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There are now numerous studies on the positive effects of palliative care (Edens, 
Harvey, & Gilden, 2010; Gade et al., 2008; Temel et al., 2010).  A recent randomized 
control trial compared patients with non-small-cell lung cancer who received palliative 
care with those who did not (Temel et al., 2010). Both groups received state-of-the-art 
cancer treatment at a major research center. Participants included 151 randomly assigned 
patients who received either standard oncological care or palliative care incorporated 
with standard oncological treatment. The palliative patients not only scored higher 
quality-of-life ratings, but also lived three months longer than those patients who only 
received aggressive measures. Overall, patients who received the early palliative 
intervention received less aggressive care measures and still had longer length of life.  
The study showed that early palliative care led to an increase in documented resuscitation 
preferences, a decrease in chemotherapy, and an increase hospice use. The study’s 
significant results showed lower costs yielded a longer life for these patients (Temel et 
al., 2010).    
Palliative care is essentially quality-of-life care.  It is not necessarily exclusive to 
end-of-life care, but it does impact and influence the type of care that is received at end of 
life.  This sub-specialty of medicine embraces all psychological, physiological, and 
spiritual symptoms that may contribute to poor quality of life.  For example, despite the 
variety in diagnoses, fatigue and pain remain some of the most debilitating symptoms of 
many illnesses (Kutner, Bryant, Beaty, & Fairclough, 2006).  Quality-of-life studies have 
shown that these symptoms improve over time with palliation involvement.  Because 
palliative care includes spiritual discussions and quality-of-life discussions, patients may 
   
13 
 
have the chance to define what constitutes individual quality of life and may be better 
able to define how to balance the risks and benefits of proposed interventions (Gade et 
al., 2008).  Palliative care may improve quality of the dying experience and improve 
deaths that lack meaning, dignity, and overall comfort (Dunn, 2005). 
Only a small percentage of cancer patients are routinely given information about 
life expectancy and alternative palliative treatments during diagnosis and treatment visits 
(Kim et al., 2008).  If a patient with a terminal illness never receives a palliative consult, 
the goals for care may be set only around treatment, with no discussion of the inevitable 
finality. Many patients with terminal illness die without ever having a discussion about 
end of life (Temel et al., 2010).  Palliative medicine is the hope for control of this 
problem. Improved communication, especially discussions on advance directives, and 
treatment preferences are key to the palliative process. These may lead to improve both 
quality and quantity of life (Griffin et al., 2007).   
The Center to Advance Palliative Care (CAPC) is a centralized resource for 
hospitals and palliative programs that offers guidance and technical assistance. CAPC has 
developed best practices and has provided standardization to the discipline (Weissman & 
Meier, 2008).  In addition to studying the variation and design of different palliative 
programs throughout the United States (Spugnardi, 2008), CAPC has also convened a 
panel to address barriers inhibiting palliative interventions, such as resource issues and 
referrals made late in the progression of illness.  As a quality improvement initiative, this 
panel developed a set of checklists for hospitals and physicians to use at registration and 
at subsequent patient visits (Weissman & Meier, 2011).   
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In March 2010, CAPC notified hospitals that the quality accreditation agency 
known as The Joint Commission developed a palliative care certification. This highlights 
the importance of having a palliative program within hospital settings, as a measure of 
healthcare quality (Center for the Advancement of Palliative Care, 2010).  Only recently 
has the Joint Commission designated palliative care as a “necessary intervention” (Edens 
et al., 2010, p. 379).   
In 2003, 25% of hospitals had palliative care programs, and programs were found 
to be more prevalent in facilities with a higher number of beds (Morrison, Maroney-Galin 
Kravolec, & Meier, 2005).  In a study examining the variability in prevalence of 
programs across the U.S., Georgia was ranked on the lower end of average, with only 20-
40% of hospitals recorded as having programs, dependent upon the hospital status: 
community, public, not-for profit or for-profit status. This is below the current national 
average of 52.8% and compares with 100% in Vermont, and 80%-plus in the District of 
Columbia, New Hampshire, and Montana. Georgia does surpass states like Mississippi at 
10% and Alabama at 16%. Variability was high across U.S. programs dependent upon the 
culture of the institution (Goldsmith, Dietrich, Qingling, & Morrison, 2008).   
The National Palliative Care Registry created by the Center for the Advancement 
of Palliative Care conducted a review of hospital palliative care programs across the 
nation, through a self-reporting mechanism, for data obtained from 2008 (2009). 420 
hospitals responded and 363 of those reported seeing patients through palliative 
consultation services.  Recommendations for future palliative work included funding a 
dedicated director, establishing a data collection and reporting mechanism consistent with 
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infrastructure, ensuring the program is aligned with the institutional mission and ensuring 
palliative care was integrated into all relevant service lines (Weisman & Meier, 2008). 
Palliative Care Models 
Palliative care models include an interdisciplinary team of physician, nurse, social 
worker, spiritual counselor, volunteer and pharmacist. This team works together to share 
“a philosophy of care and an organized, highly structured system…” (Crawford, 2011, 
p.13).  Currently, only three states in the U.S are cited as having a grade A rank on their 
reported number of palliative care programs (Spugnardi, 2008).  These include Vermont, 
Montana, and New Hampshire. In a recent review by Babcock and Robinson (2010), 
most palliative programs follow a medical model with the advanced care practice nurse 
or physician as the key component (Gade et. al., 2008; Nelson et al., 2010; Santa-Emma, 
Roach, Gill, Spayde, & Taylor, 2002). An interdisciplinary approach is consistent 
throughout all models including, at a minimum, a pain management specialist, a 
psychosocial professional, a spiritual leader, and a practitioner. The central component of 
each program is improving quality of life (Babcock & Robinson, 2011). 
Teamwork in decision making is “…an integral part of palliative care…” 
(Crawford & Price, 2003, p. 1).  Just as an organization needs a mission and vision, so 
too does an effective palliative care team (Crawford & Price, 2003). The team shares the 
suffering with the patient, thereby removing some of the burden from the patient and 
family (Wakefield, 1999).  The role of the palliative worker is to treat dying as a normal 
process and to treat a patient as a whole being instead of as an ailing organ. (Rokach, 
2005).   
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The most common palliative model cited by Meier and Beresford (2007) is 
referred to as the consultation model. Similar to other services within the hospital 
community, the attending physician consults the palliative program to assess and confer 
with their patient. Typically, in other areas of the hospital, consultation is to one 
discipline, for example a specialist physician, a physical therapist or a social worker. A 
palliative consult is made to multiple disciplines at one time. The referring physician is 
the program’s client and continues to guide patient care (Meier & Beresford, 2007).  
Communication between the managing physician and the palliative consult service is a 
key part of addressing goals of care and symptom management (Meier & Beresford, 
2007).   
A less common model, the integrative approach, exists when palliative 
philosophies are woven throughout a clinical unit, often in an intensive care setting 
(Nelson et al., 2010). Though palliative care is often seen as targeting patients with 
cancer, all diseases can potentially benefit from the services (Curtis & Rubenfield, 2005). 
Physician organizations such as the American College of Chest Physicians support an 
interdisciplinary approach in their patients with severe or life-threatening pulmonary or 
cardiac diseases, when led by the attending physician (Selecky, Hall, Varkey & 
McCaffree, 2005).       
Planning for a palliative model includes the involvement of key stakeholders-    
both clinicians and non-clinicians- for pre-program planning and education to explain 
how a palliative program can enhance a complex healthcare system. The palliative 
discipline often utilizes consult triggers, order sets for pain management, and explicit 
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policies for de-escalation of care, such as for the withdrawal of mechanical ventilation.  
Programs should develop evaluation systems to assess the effectiveness of the program 
and document the shift in quality measures post intervention (Radwany, et al., 2009).  
The continued goal is the prevention of unnecessary suffering (Priest et al., 2009).  
One of the key components of a good model is the ability to motivate and 
efficiently see referrals.  This means physicians must feel motivated to write for a 
palliative consult, and timely coordination of all palliative services must be available. A 
successful palliative program must be continuously marketed (Meier, 2005). Meier 
(2005) recommended that a program use physicians to champion the outreach to 
specialists, engage managing physicians on an individual level, mold to the facility’s 
culture, develop an easy consultation process, and maximize the ability to grow in consult 
volume. Once the consult has been initiated, one of the most important tools of the 
palliative intervention is the family conference. Variations in models include the target 
population, for example a pediatric model. Pediatric populations cite an ongoing issue 
with quality treatment for children with life-limiting illness, prompting similar 
interdisciplinary models, which may even include extended education to families and 
disciplines like art therapy (Browning & Solomon, 2005).   
Regardless of the model type, programs seek to raise awareness about the 
contributions and benefits of their services. Some different geographic model structures 
described in a study by Meier and Beresford (2006) include: (1) a closed unit, in which 
the management of the patient is transferred to the palliative physician and the patient is 
admitted to a palliative bed; (2) an open unit, where the referring physician transfers the 
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patient to the palliative unit but continues to serve as the attending physician; (3) a 
geographically separate unit in which the patient is isolated to palliative only care, staff 
and physicians; (4) an integrated unit where palliative patients occupy some of the beds 
and beds are versatile for other medically managed patients; and finally, (5) a hospice 
inpatient unit where palliative patients are intermixed with hospice patients admitted to 
the same unit. Because palliative care is tied so closely to hospice services, confusion 
may result from how the two differ. National experts recommend that hospital palliative 
care coordinate well with hospice services so that the palliative team has the ability to 
specify which service would be most appropriate for the patient (Meier, 2005).  
Palliative Care versus Hospice  
Palliative care programs in acute care hospitals may provide a transition into the 
hospice setting (Gade et al., 2008). For example, in one study, 72% of patients discharged 
from a hospital palliative program entered hospice care (Santa-Emma et al., 2002). There 
are several options that a patient may choose when diagnosed with a terminal illness in 
the U. S. The primary option is usually curative, aggressive care. Unfortunately for some, 
curative care does not always lead to more benefit than harm. In these cases, the hospice 
option better addresses the patient and family’s need (Stevenson & Bramson, 2009).  
However, admission into hospice is not limited to those whose death is imminent.  
Researchers followed 4,493 patients through the progression of their terminal 
illness, some with hospice, and others without.  The average survival was 29 days longer 
for hospice patients than for those who did not choose hospice (Connor, Pyenson, Fitch, 
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Spence, & Iwasaki, 2007), suggesting that hospice care may actually improve quality as 
well as quantity of life.   
Though hospice care correlates with patient and family satisfaction, length of stay 
is very low nationally, with referrals frequently made late in the progression of disease.  
Hospice care differs from palliative care in its general requirement for a limited 
prognosis. To receive hospice, a patient must be certified as in the last six months of life, 
whereas palliative patients are designated as life-limiting, terminal or chronic and may 
receive care for an undefined amount of time, even years (Crawford, 2011).  Hospice care 
includes palliative measures 100% of the time, but palliative care does not necessarily 
always include hospice. To understand the difference more clearly, it is important to 
define the hospice benefit.     
 Funding is provided by the federal government to support hospice care in 
certified agencies using a per diem reimbursement format. When the Medicare hospice 
benefit was started by the federal government, a major purpose was to save money. 
Terminal patients make up a large percentage of health care costs.  Research on end stage 
renal disease, for example, showed that these patients exhaust a large amount of 
healthcare dollars and resources if treatment continues in the hospital (Ross, Alza, & 
Jadeja, 2006).  At times this is appropriate, but when treatment is no longer therapeutic, 
de-escalation may embrace patient values. Hence, hospice may be a cost effective way to 
care for patients who no longer benefit from aggressive hospital care and instead should 
be cared for in alternate facilities with less aggressive care.  
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Since the advent of the Medicare hospice benefit in 1972, the funding and 
reimbursement has increased. However, a relatively low number of studies have been 
conducted on the administrative reimbursement and certification surrounding end-of-life 
care and hospice (Kirby, Keefe & Nichols, 2007).   Prior to the hospice benefit, end of 
life was reimbursed per expense and was usually costly. As a result of these fiscal flaws, 
the government felt it necessary to come up with some alternative, which resulted in the 
hospice benefit to help lessen the direct patient cost (Stevenson & Bramson, 2009). If a 
hospice is certified, Medicare then provides a flat, per diem rate. The per diem rate is 
used to fund the care including nurse, nurse assistant, equipment, and medications related 
to symptom control for the illness (Hamilton, 1994).  
In 1982, Congress qualified which specifications must be met in order to be a 
Medicare certified hospice (Hamilton, 1994).  According to Stevenson and Bramson 
(2009), the hospice benefit was originally intended primarily for cancer patients, allowing 
quality end-of-life care at home and reducing unnecessary hospitalizations. Eventually, 
the benefit expanded to other end-stage patients.  When the policy was originally 
conceived, it was more specific to a particular type of patient prognosis and included a 
cap of 210 days for use. The goal from a Medicare perspective was to replace aggressive 
care with a palliative approach for the dying (Banaszak-Holl & Mor, 1996). Savings 
would come from providing care in a less expensive setting like a home. However, 
because of the expansion of nursing home placement with hospice, the policy benefit was 
extended in 1989 to allow nursing homes to contract with hospice agencies and receive 
reimbursement.   
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To receive the benefit, a physician must certify a patient is six months or less in 
life expectancy, based upon natural disease progression.  Care is divided into two phases. 
The first consists of two 90-day periods in which the patient is allowed 90 days of 
hospice care without reassessment. The second phase consists of an unlimited number of 
60-day periods. provided the patient continues to meet the prognosis criteria even though 
they outlive the initial six months. There is no established cap on duration if criteria for 
terminal prognosis are still met. There are four levels of care within the hospice benefit. 
These include routine homecare, 24-hour continuing homecare, inpatient hospice care, 
and inpatient respite care. The per diem payment for home hospice is between $65 and 
$140 per day with a total cap per patient of $22,386.15 (Stevenson & Bramson, 2009).   
There are now nearly 5,000 hospice programs throughout the country in all fifty 
states and the District of Columbia (National Hospice and Palliative Organization, 2009). 
There has been little research reviewing hospice services and quality across facilities 
(Stevenson & Bramson, 2009).  The American population is an aging population, and 
therefore the use of palliative and end-of-life care is increasing. Hospice agencies have 
grown considerably from admitting 1,000 patients annually at the onset of the benefit to 
700,000 patients annually in 2000 (Kirby et.al, 2007).   Nursing home enrollees have 
tripled in the last 15 years. Traditional medical care is sometimes viewed as poor for end-
of-life patients and hospice is a way to improve that care (Stevenson & Bramson, 2009).   
Institutions like Skilled Nursing Facilities (SNF) and hospital based hospices have 
experienced increasing patient volumes since the expansion of the hospice benefit 
(Banaszak & Mor, 1996). These entities work with outside hospice agencies that provide 
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in-house care in the nursing home or hospital. Therefore, Medicare is paying twice, first  
for the hospice benefit and, second for the care in that institution. This may not achieve 
Medicare’s cost effectiveness goal. Although the goal of less medications and less 
aggressive care is achieved, an inpatient bed can result in high costs for institutions, and 
the baseline reimbursement may not cover these costs. There are arguments for and 
against this double payment system. Experts agree that the hospice benefit may need 
more well-defined government regulations in order to develop a true standard of care for 
hospice within an institution and to achieve the desired cost savings (Grabowski, 
Huskamp, Stevensom & Keating, 2007). 
The growth of utilization rates in the hospice benefit has led to a major increase in 
for-profit hospices, which has drastically shaped the end-of-life standard and 
reimbursement environment. Hospice facilities have become more efficient and 
competitive. In 2005, the national median length of stay in a hospice was only three 
weeks- with one third enrolling for one week prior to death- despite the fact that the 
benefit can extend for six months (Kapo et. al, 2005).  Late admission into hospice limits 
the number of palliative care services a patient receives which could reduce the quality of 
the dying experience. It also suggests there is a lack of knowledge and understanding of 
how hospice services can be added to the transitional benefit of a palliative service prior 
to hospice care (Kapo, Harrold, Carroll, Rickerson, & Casarett, 2005). 
Socioeconomic and Racial Influence on End-of-Life Treatment Decisions 
In 2011, Muni et al. published a study which examined how race/ethnicity and 
socioeconomic status (SES) may influence end-of-life care for patients in the intensive 
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care unit. There is little research on socioeconomic status and end-of-life decisions (Muni 
et al., 2011). Prior research was limited on the relationship of socioeconomic status to 
end-of-life care decisions (Bach et al., 1999; Barnato et al., 2006; Borum et al., 2000; 
Degenholtz et al., 2003; Epstein & Ayayanian, 2001; Muni, et al., 2011).  Much of the 
available research specific to race and socioeconomic status addresses access issues and 
the disparities in the receipt of necessary medical interventions (Bach et al., 1999; 
Barnato et al., 2006; Degenholtz, et al., 2003; Epstein & Ayanian, 2001; Farjah et al., 
2009; Fowler et al., 2010; Shavers & Brown, 2002). 
 Muni et al. (2011) found that SES did not consistently predict end-of life-care 
decisions but race/ethnicity did contribute. Their study differentiated race in a crude way 
by categorizing patients as either white or non-white. Non-white patients were less likely 
to complete advance directives and were more likely to choose life-sustaining treatments 
and full code status. This study highlights the limitation of grouping all minorities 
together, which made it impossible to detect specific cultural influence amongst different 
minority populations (Muni et al., 2011).   
Although SES was limited as a predictor of end-of-life decisions, both variables 
were significant predictors in the completion of advance directive documents. While 
lower SES patients likely avoided completion due to low literacy levels, factors 
influenced by race were more complex (Muni et al., 2011). One study on SES (Fowler et 
al., 2010) cited higher mortality for those without insurance. In this study, the focus was 
not on end-of-life care choices specifically, but rather the lower use of critical care 
resources in this population (Fowler et al.). Franks and Fiscella (2002) highlighted the 
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performance indicators and medically sought interventions. When evaluating a patient’s 
socioeconomic status, SES is difficult to define because data collection in the medical 
record excludes education and income. To compensate for this deficiency, Fiscella and 
Franks (2001) cited using both zip code and/or geocoded addresses to derive SES. 
Though studies of SES as a predictor of end-of-life decisions are few, studies do show 
underuse of hospice services in minority neighborhoods (Haas et al., 2007).   
End-of-life care practices are shaped by a person’s heritage, surroundings, 
religion and family. They are culturally centered. (University of Washington Medical 
Center, 2007). Trust in end-of-life care is an ongoing issue, especially among African 
American populations. The Tuskegee Syphilis Study is one of the most notorious 
landmarks to contribute to the historical trends in the data that help support this claim 
(Mitchell & Mitchell, 2009).  According to multiple studies, hospice is utilized by Blacks 
and other minorities less of the time than by Whites (Cohen, 2008; Haas et al., 2007; 
Smith, Earle, & McCarthy, 2009).   In research examining why African American culture 
influences such life choices, 205 adults were surveyed to discuss the issue of death 
(Johnson, Kuchibhatla et al., 2008). Though some themes could be identified, one 
absolute cause is not understood. The results concluded that African Americans view 
hospice in a more negative light, have religious beliefs which conflict with the 
philosophies of palliative care, show an overall lack of trust in medical systems, and are 
less likely to be comfortable discussing death or to complete an advance directive 
document (Johnson, Kuchibhatla et al., 2008).   
   
25 
 
A disconnect remains between African American healthcare and the continuity of 
choice for medical interventions (Borum, et al., 2000). In the 2010 study by Johnson and 
colleagues, African Americans were less likely to receive an initial intervention to slow 
progression of disease, but more likely to continue with the life support. Similar studies 
also found that Black patients and their families rated overall end-of-life care quality 
lower than White patients (Welch, Teno, & Mor, 2005).  African American patients who 
died were also younger on average than Caucasian patients (Johnson, et al., 2010). The 
national median life expectancy for African Americans remains six years younger than 
for Caucasians, which is at least partly explained by disparities in medical interventions 
(Epstein & Ayanian, 2001).  
Cultural history may factor into this medical care conundrum (Waters, 2001). 
There are a limited number of studies measuring specific cultural differences in care level 
choices.  In a review of the literature, only 13 studies were found on end-of-life decisions 
and African American values (Mitchell & Mitchell, 2009).  However, the existing 
literature consistently identified increased utilization of full code status and life support 
services among African Americans (Mitchell & Mitchell, 2009).  
African Americans are twice as likely as Caucasian patients to choose full code 
status instead of DNR at end of life (e.g., Borum et al., 2000; Johnson et al, 2010).  
African Americans are half as likely to withdraw aggressive care (Johnson, 2010).  These 
decisions have financial implications. Moreover, African Americans averaged 32% more 
dollars spent in the end-of-life period, mostly accounted for by funds spent on artificial 
support (Hanchate, Kronman, Young-Xu, Ash, & Emanuel, 2009).  
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Factors associated with the differences in decisions include faith conflicts, lack of 
trust in healthcare, and environmental impacts, such as community influences (Johnson et 
al., 2010).  Waters (2001) analyzed common themes among African Americans as they 
made end-of-life care decisions. These included societal and historical implications, 
reliance on family and friends to make decisions, and the impact of spiritual beliefs.  One 
study specifically looked at the spiritual beliefs of African Americans and their 
aggressive care choices. Their research found that African American families often 
believed a miracle would result in healing, thought withdrawal was a form of assisted 
suicide, and felt that God, and not the medical team should be in control. They therefore 
sometimes declined to make decisions to de-escalate care or move to palliation and 
hospice (Johnson, Katja Elbert-Avila, & Tulsky, 2005).  In an effort to explain the value 
and to increase the use of palliative and hospice medicine by the African American 
population, the Initiative to Improve Palliative and End-of-Life Care in the African 
American Community was created in 2000 (Crawley, et al., 2000).  This panel was 
designed to improve understanding of cultural implications as applied to healthcare 
choices. 
Minorities may also experience barriers because of concerns about costs and lack 
of education about end-of-life services. In a study of inner-city minorities, participants 
voiced the desire to provide care for their loved ones without help from outside entities. 
(Born, Greiner, Sylvia, Butler, & Ahluwalia, 2004).   Hospice is used less often by both 
Hispanics and African Americans, possibly because of the environmental impact and 
community influences in a person’s neighborhood (Haas et al., 2007). The Haas et al. 
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study found lower utilization of hospice services by minorities. The authors postulated 
that the difference was likely a result of lack of comprehension and understanding of 
hospice services (Haas et al., 2007). In a 2011 qualitative study report by Boyd et al., 
patients indicated that faith and community support affected their care decisions more 
than information from physicians. Patients said that information based solely from 
physicians influenced them only 2% of the time (Boyd et al., 2010). 
As a result of the effect of culture and socioeconomic influence on care decisions, 
and the continued rise in cultural disparities, there is an institutional push for culturally 
competent, patient centered treatment (Babcock & Robinson, 2011; Betancourt, Green, & 
Carrillo, 2011).  This culturally competent approach aligns the overall palliative initiative 
intervention with all dynamics influencing a patient’s decision (Crawley, Marshall, Lo, & 
Koenig, 2002).  Some hospitals have created staff education initiatives to improve 
understanding of a patient and family’s culture. Education on diverse end-of-life practice 
beliefs can act as a catalyst for change (University of Washington Medical Center, 2007).   
Code Status and Comfort Care Level Issues 
End-of life-care in hospitals has been designated “substandard” by the Institute of 
Medicine (Edens et al., 2010).  These experts suggested that too many patients receive 
aggressive care at the end of life unnecessarily, and too many patients die in intensive 
care units (ICUs).  In 2005, 20% of hospital deaths in the U.S. occurred in the ICU 
(Curtis & Rubenfield, 2005).  Interestingly, more than 90% of patients who die in an ICU 
receive recommendations from the physicians for de-escalation of care, and more than 
half of that 90% die after withdrawal or limits to life-sustaining treatments (Curtis & 
   
28 
 
Rubenfield, 2005).  Aggressive hospital technology is a routine part of end-of-life care, 
yet the issues surrounding withholding or withdrawing care are increasing (Johnson et al., 
2010). The World Health Organization (WHO) stated that palliative care is not directed at 
hastening death but instead promotes death as a natural process, provides pain and 
symptom relief, and supports the bereaved (Edens et al., 2010).   
According to one study, about one half of patients expected to live less than six 
months were put on life support during the three days prior to death (Bendaly, Groves, 
Juliar, Gregory, & Gramelspacher, 2008).  Advances in technology often make it hard to 
determine when a patient is truly at the end of life, and many issues contribute to this 
dilemma (Reynolds et al., 2005).  One such issue is the distinction between withholding 
and withdrawing treatments.  Once treatment has begun, especially if it was the patient’s 
decision to begin this course of care, family and clinicians may feel a moral obligation to 
continue the treatment.  Withdrawal decisions are often made by a surrogate when the 
patient is no longer conscious.  Furthermore, clinicians often do not make it easier for 
caregivers. When they feel uncertainty about prognosis, clinicians may err on the side of 
maximizing any “potential benefit,” despite the risk that burdens may outweigh that 
benefit (Reynolds et al., 2005 p. 471).   
Not all patients will survive their illnesses, despite advanced technologies 
(Kirchhoff & Faas, 2007).  Critical care unit services have changed greatly over the 
years, and the responsibility held by the family for the critical care patient has increased 
as the principle of autonomy replaces the strong paternalism that once resonated in 
medicine.  Patient autonomy allows healthcare professionals to defer to family for 
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decision making at the end of life.  Withholding or withdrawing treatment is a factor in 
almost 70% of deaths that occur in a critical care unit, and consent for these measures 
must come from the authorized party (Kirchhoff & Faas, 2007).  Making this decision is 
a heavy burden for families.  Emotions such as guilt, anger, regret, and even the 
anticipation of these emotions may act as barriers to letting go (Kirchhoff & Faas, 2007).    
Healthcare professionals’ sense of timing as well as their ability to understand the 
social influences and emotional state of the authorized party can have a strong impact on 
the outcome of consent to withdraw or withhold (Kirchoff & Faas, 2007).  Physicians 
tend to delay discussions of resuscitation choice until all therapeutic resources have been 
exhausted.  For example, if a Do Not Resuscitate (DNR) order is discussed before the 
attending physician conducts a thorough dialogue about poor prognosis, the family and 
patient may be resistant and unable to accept the situation (Kirchoff & Faas, 2007).  
 Semantics can also “make or break” these sensitive conversations. Vennerman, 
Harris, Perish & Hamilton (2008) examined issues of DNR orders versus AND (Allow a 
Natural Death) orders.  Based on the authorized party’s understanding of these concepts, 
there may be meaningful changes in the dialogue and choices made (Tompkins & 
Wanka-Thibault, 2001).  Families often have difficulty understanding DNR orders.  The 
idea of DNR may cause greater anxiety for families who associate it with “giving up” and 
negative connotations. On the other hand, the use of changed semantics like “Allow a 
Natural Death” increased the authorized party’s understanding during explanations of 
poor prognosis (Vennerman et al., 2008).  Families may be more receptive to the concept 
of AND rather than DNR.  Because emotional states largely define what a grieving 
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family comprehends, it may seem easier to release a loved one and allow nature to take 
its course.  When phrased as AND, decisions to restrict Cardio Pulmonary Resuscitation 
may increase not only among the family members but also among the medical team 
(Vennerman et al., 2008).  
End-of-life discussions are among the most difficult tasks required of physicians, 
largely due to negative attitudes towards dying in Western society (Cartwright, Bregje, 
Williams, Faisst, Mortier, Nilstun, et al., 2007).  Because it seemingly defeats their goal 
of healing, physicians at times do not want to convey a terminal prognosis.  However, an 
essential part of the care plan is omitted when the patient receives a terminal diagnosis 
but end of life is not discussed (Cartwright et al., 2007).  Glass and Nahapetypan (2008) 
observed that the ongoing barriers to end-of-life conversations between elders and adult 
children included family dynamics, issues with trust in surrogate decision-making, a 
general inability to determine what patients really wanted, and the fear of death.   
During many conferences with family members of terminally ill patients, doctors 
do the majority of the talking.  Families often experience communication overload, and 
they may thus be unwilling or unable to offer feedback.  Communication barriers are the 
likely result, and emotions factor into this issue (Tompkins & Wanka-Thibault, 2001).  
Such sensitive conversations require skills that not all physicians possess, such as gaining 
trust, expressing empathy, using opportune moments to discuss issues, and moving both 
doctor and family toward a more deliberative relationship (Babcock & Robinson, 2011; 
Reynolds et al., 2005).   
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Dying patients value symptom management as well as good relationships.  Most 
persons truly desire to prepare for death, not to prolong it, and they do not want to burden 
their loved ones (Ganzini, Johnston, & Silveria, 2002).  Communication between patient 
and doctor about prognosis and goals of care greatly influences the perceived quality of 
end of life.  In one study, positive family regard for physicians increased not as a result of 
treatment but rather on the basis of how well the physician listened to the needs of the 
family and patient (Biola et al., 2007).  However, among terminally ill ALS patients, 
Ganzini and colleagues (2002) found that physicians did not refer patients to hospice one-
third of the time.  Specific problems with end-of-life conversations included the initial 
efforts at communication of prognosis and expectations for the process of dying, whether 
the physician used medical jargon or overestimated the expected life-span leading to false 
hope, and how well the physician communicated throughout the illness in face-to-face 
meetings with patients and their families (Biola et al., 2007).   
Learning how to communicate about death is a vital component of physician 
education.  Basem and Usta (2006) surveyed fourth-year medical students and asked 
about their experiences in giving a poor prognosis and explaining palliation.  Of these, 
64% finished medical school without ever having watched a senior physician give a 
patient a terminal prognosis.  Instead, physicians offered bright pictures of hope and did 
not include death in the conversation (Basem & Usta, 2006).  Gawande (2010) noted that 
physicians overestimated the survival of their patients in more than 60% of cases.  
Ultimately, the best communication finds a balance between hope and reality of the 
progression of the illness (Cartwright et al. 2007).   
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Glass and Nahapetyan (2008) described end-of-life care in the U. S. as poor. 
America possesses a “…death denying culture…” which creates a barrier to conducting 
studies on dying. Likewise, well-facilitated prognosis conversations are avoided. 
Consequently, if a conversation is not initiated, a family cannot know their loved one’s 
wishes. Surrogates were found to be incorrect in guessing what the patients’ wishes were 
for the end of life 30% of the time (Glass & Nahapetyan, 2008).  In a 2001 study, pre-
operative discussions were initiated by anesthesiologists regarding end-of-life care. While 
70% of patients did have known wishes pertaining to their medical treatment, only 25% 
had spoken to their doctor about their wishes (Grimaldo et al., 2001).  
In 1991, Congress passed the Patient-Self Determination Act, which requires 
healthcare institutions to ask patients about advance directives. Advance directives allow 
a patient to make their wishes for end of life known when they cannot speak for 
themselves (Tierny et al., 2001). Although the vast majority of patients support the idea 
of completing an advance directive, only 5-15% of patients have these documents 
(Grimaldo et al., 2001). 
One community has taken this message to heart. In Lacrosse, Wisconsin, 85% of 
persons studied post mortem had completed an advance directive (Gawande, 2010).  The 
Lacrosse project, Respecting Choices, targeted patients with congestive heart failure 
(CHF), end stage renal disease, and other illnesses, focusing on advance care planning 
(Hammes, 2003). The Lacrosse practice has been successful due to their focus on an 
ongoing process of constant discussion surrounding end of life. In addition, they are 
averaging cost savings between $3,000 and $6,000 annually per patient, compared with 
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historical U.S. averages because of the advance care planning (Gunderson Lutheran, 
2010).   
However, even under ideal circumstances, not every patient will be able to 
complete a written advance directive (Milstein & Raingruber, 2007). If a patient did not 
complete an advance directive and can no longer communicate, the family becomes the 
source of decision making. Attention should be placed on transition to death for families, 
particularly when discussions did not occur prior to the patient’s unconscious state.  The 
literature supports shared decision making between the physician and the family with 
quality end of life as the primary focus (Milstein & Raingruber, 2007).   
  It is important to consider what patients and families may be experiencing. Their 
emotions may affect their ability to process what is being explained (McSherry, Kehoe, 
Carroll, Kang, & Rourke, 2007). Palliative care uses the multidisciplinary approach to 
meet the needs of the family, with discussions centered on patient wishes, quality of life, 
advance care planning, and needed support for all involved (Babcock & Robinson, 2011; 
Fineberg, 2005).   
According to Menkin (2007), tools such as cards that rank quality of life have 
been developed to aid professionals with end-of-life care decisions. However, the 
palliative team likely remains the best tool for communication. In the Transitions 
palliative model developed by MCCG, communication is the cornerstone of decision 
making (Babcock & Robinson, 2011). In their groundbreaking article in the Journal for 
Palliative Medicine, Babcock and Robinson (2011) delineated the critical components of 
their counselor-initiated model. Transitions Counselors assess the whole patient situation 
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by considering barriers, family availability, differing points of view, health literacy, 
language, age, family hierarchy, quality of life, advance directives, and cultural and 
spiritual impacts. This assessment often requires multiple meetings with family members 
and often entails several hours of quality communication prior to the actual consultation 
with the palliative care physician. The success of the consult is found in the education 
provided and the communication process, regardless of the choices made for end-of-life 
care. Even after all the information is given, the patient and family may choose death on 
artificial support as representative of their autonomy and values at end of life. This 
unique palliative model systematically identifies and assesses potential barriers to 
communication often before they occur (Babcock & Robinson, 2011). 
Costs at End of Life 
End-of-life care, defined in this paper as care for the terminally ill patient, 
constitutes 27% of the Medicare budget in the U. S. (Hogan, Lunney, Gabel, & Lynn, 
2001). Experts expect that the elderly, ill and dying populations will double in the next 15 
years (Appleby, 2006). No appropriate level is known for spending at end of life, and 
values about quality of life at end of life are different for everyone. However, many 
populations with both chronic and acute illness could benefit from a better, more cost 
efficient care plan, especially those with terminal illness (Luce & Rubenfield, 2002).   
Medicaid recipients also incur high costs for medical care at the end of life which 
might be drastically reduced by organized palliative care interventions. Research by 
Morrison et al. (2011) showed an approximate $6,900 reduction per admission, per 
patient using palliative care.  However, spending as a disease advances appears “U-
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shaped, rising again toward the end” (Gawande, 2010, p. 3).  The inability of 
government-funded agencies to assess expanding medical technologies in a financially 
efficient manner may contribute to the rising costs (Luft, 2009). 
A well-designed palliative model may reduce costs by several thousand dollars 
per admission (Crawford, 2011; Spugnardi, 2008).  Major cost savings come from fewer 
tests and decreased critical care utilization (Morrison et al., 2008). For example, one 
study examined a palliative program for patients admitted to the hospital with chronic 
pain. When correct palliative care was used to standardize a patient’s symptom 
management, more than $2 million were saved (Morrison et al., 2008).  Other research 
suggests that at least 10% is saved by palliative care, and up to 20% is saved, when 
comparisons are made to cases with a higher length of stay (Hanson, at al., 2008).  The 
National Framework and Preferred Practices for Palliative and Hospice Care Quality 
Consensus Report added that palliative services can be deemed a best practice and lead to 
enhanced performance (National Quality Forum, 2006). 
The difficulty of identifying palliative savings is the challenge of using an 
appropriate measurement tool to determine avoided costs. One way to identify savings is 
to compare palliative patients to non-palliative (Hanson et al., 2008), though this has 
limitations because of the variability in case complexities.  In one study, non-palliative 
and palliative total costs were compared along with Diagnostic Related Group (DRG) 
coding to adjust for disease complexity.  Palliative patients averaged $35,824 per hospital 
stay, compared with $42,731 for non-palliative patients (Bendaly et. al., 2008).  
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The Quality-Adjusted Life Year model (QUALY) is one financial model which is 
currently utilized for cost reduction. Wright (2009) questioned whether the QUALY, 
utilized by other countries as a tool for cost reduction at the end-of- life could truly 
determine quality of a person’s life. Allocation of resources at end of life seems to occur 
more readily in other countries than in the U.S (Wright, 2009).  Research shows that 
evidenced-based allocations of resources may decrease cost by 38% (Gunes & Yaman, 
2005). Much of the ethical debate in American healthcare involves inequity of costly 
resources given to patients who may not benefit (Newbold, Eyles & Birch, 1995). Cost 
effective analysis attempts to use the QUALY scale by assessing the benefit of a 
therapeutic measure based on years of life combined with health related quality of life 
measurements (Gunes & Yaman, 2005). Research suggests that cost reductions are best 
accomplished in critical care units due to the expense of this environment. Cost 
reductions depend on lower use of potentially life-sustaining treatments for patients with 
terminal illnesses (Luce & Rubenfield, 2002).  
 Decreasing length of stay (LOS) may prove cost efficient when the overall 
hospital stay decreases or LOS in a medical intensive care unit goes down (Norton et al., 
2007).  The Center for the Advancement of Palliative Care (CAPC) has conducted a 
study to assess the reasons behind prolonged LOS. The CAPC proposes user-friendly 
templates to prove financial savings on length of stay and days saved (Meier & 
Beresford, 2008).   
There is a national initiative to reduce overall mortality rates in hospitals. This 
initiative views mortality in a hospital as an avoidable adverse event, which may conflict 
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with a palliative approach which views death as an expected and normal outcome 
(Institute for Healthcare Improvement, 2005).   
Summary 
End-of-life care is expensive (Zhang, et al., 2009; Emanuel & Emanuel, 1994; 
Luce & Rubenfield, 2002).  Some researchers have argued this is attributable to U.S. 
culture, while others postulated that effective advancements in medical technology inhibit 
the ability to grasp prognosis (Glass & Nahapetyan, 2008; Reynolds, et al., 2005). No 
appropriate level is known for spending at end of life, and values in quality of life at end 
of life differ with each individual.  Historical trends for end of life document sustained 
high costs in the last year of life (Emanuel & Emanuel, 1994; Luce & Rubenfield, 2002).  
However, despite increasing use of aggressive hospital technology at the end of life, 
withholding and withdrawing care are also increasingly common (Johnson et al., 2010; 
Norton, et al., 2007; Spugnardi, 2008; Morrison et al., 2011) 
Dying patients value symptom management and good relationships with their 
physicians. Most truly desire to prepare for death and not to prolong it. They do not want 
to burden their loved ones (Ganzini et al., 2002).  Communication between patient and 
doctor about prognosis and goals of care directly impacts the quality of a patient’s end-
of-life experience (Biola, et al., 2007).    
Muni et al., (2011) found that socioeconomic status did not consistently predict 
end-of life-care decisions but that race/ethnicity may be a more powerful contributor. 
Trust in end-of-life care is an ongoing issue, especially amongst African American 
populations.  African Americans seem to view hospice in a more negative light, as they 
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sometimes have religious beliefs that conflict with the philosophies of palliative care, 
have less trust in medical systems, and are less likely to be comfortable discussing death 
or to complete advance directives (Johnson et. al., 2008). Cultural and socioeconomic 
influences continue to be an understudied area of the literature (Mitchell & Mitchell, 
2009; Muni, et al., 2011).   
There are numerous studies on the positive effects of palliative care (Edens et al., 
2010; Gade, et.al, 2008; Temel et al., 2010).  Researchers have proven that appropriate 
palliative and hospice care at end of life can lengthen life in comparison to aggressive 
care without palliation (Temel et al., 2010; Gawande, 2010). Palliative care is a 
multidisciplinary approach to the relief of symptoms and suffering and the improvement 
of overall quality of life during illness. This care is patient and family centered.  
Palliative care consultation includes a discussion surrounding long term goals of the 
patient, including advance care planning and/or care at the end of life(Griffin et al., 
2007). The success of the consult is in the education provided and communication 
process, regardless of the choices made for end-of-life care. Even after all the information 
is given, the patient and family may choose death on artificial support to be 
representative of their autonomy and values at end of life (Babcock & Robinson, 2011). 
In a 2008 survey of hospital based palliative programs, Georgia was ranked on the 
lower end of average, with 20% to 40% of hospitals recorded as having these programs 
(Goldsmith at al., 2008).   There are many variations in hospital palliative program 
models (Meier & Beresford, 2006), the most common being the consultation model 
(Meier & Beresford, 2007).  There is a national recommendation, for hospital-based 
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palliative programs to coordinate closely with hospice (Meier, 2005). Palliative care 
programs in the hospital setting meet some of the limitations of hospice inadequacies, 
providing a smoother transition from hospital to hospice (Gade et al., 2008). In one study, 
72% of patients who were discharged alive from a hospital-based palliative program were 
discharged to hospice (Santa-Emma et al., 2002). Several studies have documented the 
cost savings and decreases in length of stay which result from palliative care in the 
hospital (Bendaly et al., 2008).  While not all hospitals have palliative program, the 
majority of hospitals with 50-plus beds, have a well-established program and benefit 
from the services (Morrision et al., 2005).  
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CHAPTER 2 
 
RESEARCH QUESTIONS AND HYPOTHESES 
Research Questions 
The following research questions were explored: 
#1: Is there a difference in code status pre and post palliative intervention? 
a. according to gender 
b. according to race 
c. according to age 
d. according to education (socioeconomic status) 
e. according to income (socioeconomic status) 
f. according to payer source (socioeconomic status) 
g. according to disease distribution 
#2: Is there a difference in Stage IV, (comfort measures status) pre and post 
palliative intervention? 
a. according to gender 
b. according to race 
c. according to age 
d. according to education (socioeconomic status) 
e. according to income (socioeconomic status) 
f. according to payer source (socioeconomic status) 
g. according to disease distribution 
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#3: Is there a difference in number of discharges to hospice following a palliative 
intervention? 
a. according to gender 
b. according to race 
c. according to age 
d. according to education (socioeconomic status) 
e. according to income (socioeconomic status) 
f. according to payer source (socioeconomic status) 
g. according to disease distribution 
#4: Is there a difference in cost of care by length of stay pre and post palliative 
intervention? 
a. according to gender 
b. according to race 
c. according to age 
d. according to education (socioeconomic status) 
e. according to income (socioeconomic status) 
f. according to payer source (socioeconomic status) 
g. according to disease distribution 
#5: Is there a difference in cost per days saved post palliative intervention? 
a. according to gender 
b. according to race 
c. according to age 
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d. according to education (socioeconomic status) 
e. according to income (socioeconomic status) 
f. according to payer source (socioeconomic status) 
g. according to disease distribution 
h. according to hospice 
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Hypotheses 
 In addition, the following hypotheses were tested: 
 #1: No statistical differences will be detected relative to code status pre and post 
palliative intervention. 
a. according to gender 
b. according to race 
c. according to age 
d. according to education (socioeconomic status) 
e. according to income (socioeconomic status) 
f. according to payer source (socioeconomic status) 
g. according to disease distribution 
#2: No statistical differences will be detected relative to Stage IV comfort 
measures pre and post palliative intervention.  
a. according to gender 
b. according to race 
c. according to age 
d. according to education (socioeconomic status) 
e. according to income (socioeconomic status) 
f. according to payer source (socioeconomic status) 
g. according to disease distribution 
#3: No statistical differences will be detected relative to hospice discharge post 
palliative intervention. 
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a. according to gender 
b. according to race 
c. according to age 
d. according to education (socioeconomic status) 
e. according to income (socioeconomic status) 
f. according to payer source (socioeconomic status) 
g. according to disease distribution 
#4: No statistical differences will be detected relative to cost of care per length of 
stay post palliative intervention. 
a. according to gender 
b. according to race 
c. according to age 
d. according to education (socioeconomic status) 
e. according to income (socioeconomic status) 
f. according to payer source (socioeconomic status) 
g. according to disease distribution 
#5: No statistical differences will be detected relative to cost of care per days 
saved post palliative intervention. 
a. according to gender 
b. according to race 
c. according to age 
d. according to education (socioeconomic status) 
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e. according to income (socioeconomic status) 
f. according to payer source (socioeconomic status) 
g. according to disease distribution 
h. according to hospice discharge 
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CHAPTER 3 
 
METHODS 
Purpose of the Study 
 The purpose of this study was to examine differences in treatment level at the end 
of life according to socioeconomic status and race. Data included treatment level 
measurements before and after the palliative intervention from a secondary data set.  
Further, this study looked at the influence of socioeconomic status and race on code 
status, comfort measures, discharge, and costs, for patients at the end of life who had 
experienced the palliative program.  
This chapter is organized into the following sections to profile study methods: (1) 
design of the study; (2) sampling plan; (3) instrumentation; (4) collection and treatment 
of data; and (5) analysis and interpretation of data. 
Design of the Study 
This study was a quantitative research design which utilized pre-determined 
retrospective performance data. Variables under study were assessed via a cross-sectional 
research design (Creswell, 2010). The palliative intervention was defined as a clinical 
assessment and family conference with a palliative practitioner and a counselor from the 
MCCG Transitions Palliative Care Team. The intervention was a dependent variable for 
the total population targeted. All sample population participants had received the baseline 
intervention defined above prior to post measurements.  
Independent, predictor variables included race, gender, age, socioeconomic status, 
and disease.  Race was categorized as Caucasian, African American, other, and unknown. 
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Other included outlier races. Two variables were used to determine socioeconomic status. 
These included address and payer source. Address was used to determine education and 
income level through the geocoding mechanism. The geocoding software provided 
mapping technology to define the subdivisions within a census tract. The census tract 
defined the socioeconomic status. (Chen et al., 1998).   Payer source was grouped into 
categories of insured and underinsured and helped determine socioeconomic status for 
those patients with an unidentifiable address (Muni et al., 2011).  
Dependent outcome variables included pre and post measurements for dying with 
quality and comfort measures. More specifically, these variables included code status pre 
and post palliative intervention, comfort measure status pre and post palliative 
intervention, discharge distribution to hospice, and cost categorized by length of stay 
(LOS), pre and post intervention.  
 Patient age, patient sex, and disease distribution were included in regression 
analysis. Age was categorized using the National Registry for Palliative Care, and 
categories included ages 2-17, 18-65, and 65 plus. Minors were removed after 
categorizing for protection of a vulnerable population. Disease distribution was split into 
two categories of cancer and no cancer based on National Palliative Registry data 
reporting (CAPC, 2009). 
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Sampling Plan 
This study served as a secondary analysis of a unique clinical database at the 
Medical Center of Central Georgia (MCCG). MCCG started their palliative program in 
2004 under the direction of the Center for the Advancement of Palliative Care (CAPC) 
and through the use of the Transitions and Palliative Care Therapy Model (TPCT) 
(Babcock & Robinson, 2011).  Currently, there are more than 11,330 patients who have 
been admitted to the program (Babcock & Robinson, 2011).  This research utilized data 
from patients from the years 2008-2010 because data the instrument was consistent from 
2008. As an end date for sample data, December 31, 2010, was chosen to ensure that no 
active patients were included in the data set.  All patients entered into the database for 
these three years, with the exception of five minor patients, were eligible for this study. 
N=2,920 patients was the target population and sample.  
Instrumentation 
 The data for this study was extracted from a unique clinical database. The 
Footprints database was used to record data from patients admitted to the palliative 
program at MCCG. MCCG began using Footprints in the summer of 2006. Access to 
patient charts allowed for accurate data to be entered directly into the system before and 
after a palliative intervention. The database included demographic, socioeconomic, 
disease distribution, and treatment status fields. New fields were added to the instrument 
up until 2008, from which point the instrument remained consistent. Hence, a data 
collection period of 2008-2010 was chosen. Since this was a secondary data analysis, no 
new instrument was used to collect further data. The Principal Investigator did not have 
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access to the medical record. However, the medical record was used by a third party at 
MCCG to retrieve any missing data, including payer source.  
Collection and Treatment of the Data 
This research was approved by the Georgia Southern University Institutional 
Review Board (IRB) and approved by the Medical Center of Central Georgia IRB 
representative. The authorized facility key informants were contacted prior to the study to 
ask for their participation, and a data cooperation agreement was proposed. The Principal 
Investigator also went through the necessary steps to become a Medical Center of Central 
Georgia doctoral intern including orientation, compliance education, health screenings 
and photo identification process. This was to ensure protection and privacy of the patients 
studied. A secondary data agreement was also executed and signed by the cooperating 
facility, MCCG.  
The Principal Investigator looked at data retrospectively. Data collection occurred 
between 2004 and 2010. However, the Footprints database was used from 2006 and 2010. 
Fields were added up until 2008. Therefore, data were limited to the more recent years.   
Duplicated patients were marked by last visit to determine whether a change ultimately 
occurred after the intervention.  Data was de-identified for the protection of patient 
privacy.  De-identification took place through the use of the unique clinical identifier 
number, and finally through coded identity. Patients were coded, patient 1, patient 2 
continued.    
Data was extracted, cleaned and coded from patient medical records and the 
Footprints clinical database by a trained third party working with the Principal 
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Investigator to ensure objectivity and patient privacy. This assured compliance with the 
terms set forth by the Georgia Southern University Institutional Review Board and the 
MCCG secondary data agreement. Data were linked from both data sources using a 
unique clinical identifier which aligned with the medical record number for verification. 
Data were cleaned and coded into descriptive fields which included age by category, sex, 
and disease distribution by category. Dependent variable fields were cleaned and coded 
into race and payer source. Address was not coded for verification reasons and to allow 
for geocoding following initial coding.  
Geocoding acted as a surrogate indicator of the patient’s socioeconomic status 
and ultimately defined elements of income and education through the process of a three 
level processing system and GIS Arch 10.0 software. The addresses were cleaned into 
fields of street number and name, zip code and unique patient identifier. Addresses were 
processed through the GIS software to map the address to the point. A shapefile for each 
of the eight designated counties, including Bibb and surrounding rural areas, Baldwin, 
Crawford, Houston, Jones, Monroe, Peach, and Twiggs Counties were cross matched to 
define the census tract for each point. Population data was processed and downloaded 
from the census.gov site for each of the eight counties and formatted to be cross matched 
with the GIS mapped tracts. From this point, the data was imputed back into the original 
set and each mapped address was assigned a known census tract, income and education 
level. Income and education variables were then coded categorically. 
Outcome variable fields were cleaned and coded into code status, pre and post 
intervention; comfort measure status, pre and post intervention; death and discharge; and 
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discharge to hospice. Cost was coded and categorized by length of stay (LOS), pre and 
post intervention, and a mean days saved variable was identified. Categories for LOS 
were based on outside literature (e.g., Klein, Ross, Adams, & Gilbert, 1994). Further, a 
cost assessment was completed using the literature and tools suggested by the Center for 
the Advancement of Palliative Care (CAPC, 2008).  
Analysis and Interpretation of the Data 
 The data was analyzed in multiple phases. Lone predictor variables were analyzed 
to determine care level outcomes as a matched pair design in a 2-by-2 table format using 
the McNemar test for symmetry (Norman & Streiner, 2000). The Likelihood Ratio Chi 
Square test was used to determine discharge to hospice. In order to further examine 
differences in end-of-life treatment measures further, and the association between 
variables and care levels, multivariate analysis was used in a Logistic Regression test. 
Logistic regression was used for cross sectional, retrospective data (Lachin, 2000). 
McNemar-Bowker tests were used to determine length of stay before and after the 
intervention. Finally, the t-test was used to look at the comparison of means in days 
saved, and Bonferroni in conjunction with ANOVA was used to analyze days saved 
relative to the hospice predictor variable. (Norman & Streiner, 2000).   
 
 
 
 
 
 
 
   
52 
 
CHAPTER 4 
RESULTS 
The purpose of this study was to examine differences in treatment level at the end 
of life according to socioeconomic status and race following a palliative care 
intervention.  Data included treatment level measurements before and after the palliative 
intervention using a secondary data set.  Length of stay and days saved aligned with 
treatment level were also examined relative to socioeconomic status and race.  
This chapter is organized into the following sections to present the study results: 
(1) sample characteristics; (2) explanation of the geocoding process; (3) analysis of 
research questions and hypotheses; (4) systemic sample; (5) summary of results. 
Sample Characteristics 
Data from 2,920 patients were used for this analysis from a pre-collected database 
where collection had occurred while the patients were actively admitted into the Medical 
Center of Central Georgia (MCCG). Patients were chosen based on requirements set by 
the researcher from a pre-determined data set from years 2008-2010. Participants of the 
study represented patients from different demographic categories as profiled in table 4.1. 
Six descriptive, demographic variables were included as potential predictors of treatment 
options. Variables included gender, race, age, education level, income level, the patient’s 
payer source and their disease. Outcome variables for which pre and post measurements 
were taken included code status, no code to full code and full code to no code, care level 
status from aggressive to comfort care and from comfort to aggressive care as profiled in 
table 4.2. The post measurements were taken following the palliative intervention. 
Hospice discharge was measured for all patients. This included whether or not the patient 
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was admitted to hospice on discharge and the mortality of patients in the hospital. Lastly, 
measurements were taken on length of stay pre and post palliative intervention and days 
saved as a result of the intervention.  
Female patients accounted for 1,473 (51.8%) of the participant population and 
males accounted for 1,362 (47.9%) of the participant population. Eight (.3%) of the 
charts were missing gender information. For the purpose of this study and because of 
limited information on other minorities, the study only included racial categories of 
White 1,432 (50.4%) and Black 996 (35%), whereas all unknown, missing and other 
races 415 (14.6%) were not included in the analysis.  Age was defined in categories of 
18-65 for 934 (32.9%) of patients and over 66 for 1,786 (62.8%) patients. Minors were 
not included in the sample and there were 123 patients (4.3%) whose age was missing or 
unknown. Socioeconomic status was defined through variables of education, income and 
payer source.  Education was determined through the process of geocoding explained 
below, and divided into categories of less than high school 351 (12.3%), high school 
diploma, 1,054 (37.1%) and college, 339 (11.9%). Some patients, 1,099 (38.7%) were 
missing education information because no census match was achieved by address.  
Income levels were split into categories of  <$10,000 annually for 97 (3.4%), 
$10,000-29,999 annually for 687 (24.2%), $30,000-49,999 annually for 121 (4.3%), 
$50,000-74,999 annually for 28 (1%) and >$75,000 annually for 568 (20%). Again, 
missing data was most prevalent in income categories accounting for 1,342 (47.2%) of 
patients who could not be matched by address. Categories of payer source included the 
insured 2,323 (81.7%) defined as those patients with Medicare, private insurance and 
veterans sources and the underinsured 520 (18.3%) defined as those with Medicaid, no 
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insurance, self pay or unknown. Disease distribution categories included cancer, 641 
(22%) non-cancer patients, 1,989 (68%), and missing disease distribution for 285 (10%) 
of patients.  
Table 4.1 
Sample patient characteristics 
Variable N Percent 
Gender  Female 1473 51.8% 
                Male 1362 47.9% 
                Missing 8 0.3% 
Race       White 1432 50.4% 
                Black 996 35% 
                Missing 415 14.6% 
Age         18-65 934 32.9% 
                66 and older 1786 62.8% 
                Missing 123 4.3% 
Education Less than HS 351 12.3% 
                  HS Diploma 1054 37.1% 
                  College 339 11.9% 
                  Missing 1099 38.7% 
Income    Less than 10,000 97 3.4% 
                  10,000-29,999 687 24.2% 
                  30,000-49,999 121 4.3% 
                  50,000-74,999 28 1.0% 
                  75,000 or more 568 20.0% 
                  Missing 1342 47.2% 
Pay Source  Insured 2323 81.7% 
                     Under insured 520 18.3% 
Disease Distribution  
                  Cancer 
641 22% 
                  No Cancer 1,989 68.2% 
                  Missing 285 10.2% 
 
Outcome variables profiled in table 4.2 show N= number of total patients for each 
category and percentage of patients relative to code status, comfort/aggressive measures, 
discharge to hospice, mortality rates and length of stay for the total population. Data in 
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this table does not differentiate according to predictor variables, but rather looks at 
outcomes for the total population before and after the palliative intervention.  
Before the palliative intervention 772 patients (27.2%) of patients were DNR or 
no code status and 2,071 (72.8%) were full code status. After the intervention, the vast 
majority 2,344 (82.4%) of patients were made DNR or no code and 499 (17.6%) of 
patients remained a full code. There were 130 (4.6%) of patients receiving comfort care 
prior to the intervention and 2,713 (95.4%) receiving aggressive care. Following the 
intervention, 1,232 (43.3%) changed to comfort measures, while 1,611 (56.7%) continued 
to receive some aggressive measure. After the intervention, discharge measurements 
showed that 493 (17.3%) of patients used hospice care, 481 (16.9%) did not use hospice, 
1,515 (53.3%) died in the hospital with hospice or palliation only, and there was missing 
data for discharge on 354 (12.5%) of patients. 
Finally, in table 4.2 length of stay before and after the palliative intervention was 
measured. Before palliative involvement categories of 0-6 days show 1,665 (58.6%), 7-
14 days for 550 (19.3%) patients, 15-21 days for 127 (4.5%) patients and outliers >21 
days for 352 (12.4%) of patients. There was missing data on length of stay before the 
consult for 149 (5.2%) of patients. Following the intervention, length of stay measured as 
follows. The most prevalent post length of stay measure was 0-6 days for 2,100 (73.9%) 
patients. There were 438 (15.4%) patients whose length of stay was 7-14 days.  Patients 
with a length of stay 15-21 days decreased to 77 (2.7%) and patients with >21 days 
decreased to 115 (4%). There were 113 (4%) of patients with missing data.  
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Table 4.2 
Sample outcome variables 
Variable N Percent 
Prior Code      DNR 772 27.2% 
                          Full 2071 72.8% 
Ending Code   DNR 2344 82.4% 
                          Full 499 17.6% 
Prior Comfort Comfort only 130 4.6% 
                          Aggressive 2713 95.4% 
D/C Comfort  Comfort only 1232 43.3% 
                          Aggressive 1611 56.7% 
Mortality      Died hosp. 1515 53.3% 
Discharged prior 1328 46.7% 
Hospice D/C   Used after 493 17.3% 
No Hospice 481 16.9% 
Died in hosp. 1515 53.3% 
Missing 354 12.5% 
LOS before     0-6 1665 58.6% 
                         7-14 550 19.3% 
                         15-21 127 4.5% 
                         > 21 352 12.4% 
                        Missing 149 5.2% 
LOS after        0-6 2100 73.9% 
                         7-14 438 15.4% 
                         15-21 77 2.7% 
                         > 21 115 4.0% 
                        Missing 113 4.0% 
Geocoding to Define Socioeconomic Status 
Whereas race, age and gender variables were taken at face value from medical 
records and the footprints data source, income and education level was derived from the 
address included in the patients’ medical records. This required use of Arch GIS 
software, 10.0. Patients were de-identified with a unique identifier number for 
verification and addresses from the chosen surveillance area were imputed into the GIS 
software. The surveillance area was identified based on the majority MCCG patient 
population. These counties included Bibb County where MCCG is located and the 
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surrounding counties of Baldwin, Crawford, Houston, Jones, Monroe, Peach and Twiggs, 
as profiled in table 4.3. If the software was able to match the address to a point in the 
surveillance area, the census tract was identified. Census tracts are a geographic division, 
which in decreasing order fall below state and county to smaller divisions for heightened 
specificity and lower margin of error (Chen et al, 1998).  
 Blocks and block groups are smaller than census tracts but were not obtainable 
using the variables at an acceptable margin of error (Skinner, J Atlanta Regional 
Commission, 8/3/2011). The tract data was then merged with the American Community 
Survey 2005-2009 census data for Georgia counties, socioeconomic information (US 
Census Bureau, 7/28/11).   In addition to processing the information for each county, 
social and economic information for the Georgia population overall was processed.  In 
Georgia, 8.3% of households make less than $10,000 annually, a little over 50% make 
under $50,000, and 18.8% make $50,000-$74,999 annually. This computes to almost 
70% of the state population making under $75,000 annually. Higher income categories 
range from 3.7-12% of the population in Georgia, but did not represent a significant 
majority of this patient population (US Census Bureau, 8/3/11).  
Education averages from Factfinder showed 10.8% of the state population having 
received a less than high school education. There are 29.7% of Georgians who have high 
school equivalency and 53.2% who have some college which may include associate to 
graduate level (US Census Bureau, 8/3/11). 
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Figure  4.1. Geocoded Addresses Mapped  
Population information was processed using variables for income and education 
level for each of the named counties. Stratification was set by the US census bureau. 
Income was stratified by county, tract and race. Education level was stratified by county, 
tract, and by gender for adults over the age of twenty-five. In the census population data 
there were 100-plus different categories of variables for education and income. For 
example, within the education variable there were variable divisions for nursery school 
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for females over the age of twenty-five up to graduate degrees. Because of the high 
number of divisions in Factfinder, the Principal Investigator combined variable categories 
for the purpose of this study. Counties had such a wide array of diversity and margin of 
error for income and education levels such that no acceptable mean could be achieved by 
combining the eight counties. Each patient was looked at within their own tract.  
The census tract number identified through the geocoding process was then 
matched back to the population data and imputed into the patient dataset. Address was 
not always known for every patient and further, some addresses included lot numbers, 
P.O. box numbers, nursing homes, transferring facilities and other errors making some 
addresses unidentifiable and without match. For this reason, socioeconomic status under 
the auspices of income and education was limited to n= 1,794 total matches. The margin 
of error varied dependent upon the county and the variable measured. Inferences were 
made by using known patient race and sex combined with the coordinating measurement 
within the tract.  
Analysis of the Research Questions and Hypotheses 
The prospective cross-sectional large sample data in this study were analyzed 
using the McNemar test of symmetry for matched pairs of full code to no code and no 
code to full code before and after the palliative intervention. The McNemar test was also 
used to match pairs of comfort to aggressive care and aggressive to comfort care prior to 
and following the intervention. A 2-by-2 table format was used and data were treated as a 
paired observation.  
Following the test of symmetry a multivariate analysis was conducted through a 
logistic regression model to look at multiple exposure or predictor variables to determine 
   
60 
 
which would have impact on outcomes of code status change and change to comfort or 
aggressive measures.   
Research Question #1 
Is there a difference in code status pre and post palliative intervention? 
Null Hypothesis #1 
No statistical differences will be detected relative to code status pre and post 
palliative intervention? 
McNemar's test was used to test for symmetry in change yielding a p-value 
<0.0001, indicating significance. The McNemar analysis was run to see if the change 
from full code to no code was the same as the change from no code to full code.  As 
profiled in table 4.3 the change from full code to no code is 55.4% as compared to 0.1% 
changing from no code to full code.  Thus the intervention has both statistical 
significance and a clinical impact on code status.  The odds ratio for a matched pair 
design is OR=575 with a 95% confidence interval (169, 1620).  This means that the odds 
are about 575 times greater to change to Do Not Resuscitate. 
Table 4.3  
Total population code status change following the intervention 
 After Total 
Before Full Code No Code  
Full Code 496(17.4%) 1575 (55.4%) 2071 
No Code 3 (0.1%) 769 (27%) 772 
Total 499 2344 2843 
 
Research Question # 1a 
Is there a difference in code status according to gender pre and post palliative 
intervention? 
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Hypothesis #1a 
No statistical differences will be detected by gender relative to code status pre and 
post palliative intervention? 
The McNemar Test to test for symmetry in change yielded a p-value<.0001 for 
both males and females when only gender was used as a predictor variable to look at code 
status changes. As profiled in tables 4.4 and 4.5, the change from full code to no code 
was 53.4% as compared to a 0.1% change from no code to full code in females. Among 
males, there was a 57.6% change from full code to no code as compared to a 0.1% 
change from no code to full code. For females, the odds ratio for a matched pair design is 
OR=393 with a 95% confidence interval (98, 1574).  For males, the odds ratio for a 
matched pair design is OR=785 with a 95% confidence interval (110, 5579).  The 
intervention has both a statistically significant difference and a clinical impact on code 
status for both males and females, with minimal difference detected between the two.   
Table 4.4  
Code status change according to gender-females 
Female After Total 
Before Full Code No Code  
Full Code 256(17.4%) 786(53.4%) 1042 
No Code 2(0.1%) 429(29.1%) 431 
Total 258 1215 1473 
McNemar's  p<0.0001; OR= 393 with 95% C.I. (98, 1574) 
 
Table 4.5 
Code status change according to gender-males  
Male After Total 
Before Full Code No Code  
Full Code 239(17.5%) 785(57.6%) 1024 
No Code 1(0.1%) 337(24.7%) 338 
Total 240 1122 1362 
McNemar's  p<0.0001; OR= 785 with 95% C.I. ( 110, 5579) 
 
Research Question #1b- Race 
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Is there a difference in code status according to race pre and post palliative 
intervention? 
Hypothesis #1b 
No statistical differences will be detected by race relative to code status pre and post 
palliative intervention? 
The McNemar Test to test for symmetry in change yielded a p-value<.0001 for 
both Black and White using only race as a predictor variable to look at code status 
changes as profiled in tables 4.6 and 4.7. These showed the change from full code to no 
code was 56.7% as compared to a 0.1% change from no code to full code in Blacks with 
the odds ratio for a matched pair design of OR= 565 with a 95% confidence interval 
(79,4018). Among Whites, there was a 55.2 % change from full code to no code as 
compared to a 0.1% change from no code to full code with an odds ratio for a matched 
pair design of OR=396 with a 95% confidence interval (99,1584)  as profiled in table 4.8.  
Table 4.6 
Code status change according to race-Blacks   
Black After Total 
Before Full Code No Code  
Full Code 220(22.1%) 565(56.7%) 785 
No Code 1(0.1%) 210(21.1%) 211 
Total 221 775 996 
McNemar's  p<0.0001; OR= 565 with 95% C.I. (79, 4018) 
 
Table 4.7 
Code status change according to race-Whites 
White After Total 
Before Full Code No Code  
Full Code 173(12.1%) 791(55.2%) 964 
No Code 2(0.1%) 466(32.5%) 468 
Total 175 1257 1432 
McNemar's  P<0.0001; OR= 396 with 95% C.I. ( 99, 1584) 
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The intervention has both a statistically significant and a clinical impact on code 
status for both Black and Whites with differences detected. 
Research Question #1c 
Is there a difference in code status according to age pre and post palliative 
intervention? 
Hypothesis #1c 
No statistical difference will be detected by age relative to code status pre and post 
palliative intervention? 
The McNemar Test to test for symmetry in change yielded a p-value<.0001 for 
ages 18-65 and 66-plus when only age was used as a predictor variable to look at code 
status changes between categories of 18-65 and 66-plus as profiled in tables 4.8 and 4.9.   
Tests showed the change from full code to no code was 57.7% as compared to a 0.2% 
change from no code to full code in those aged 18-65 with an odds ratio for a matched 
pair design of OR=269 with a 95% confidence interval (67,1080). Among those aged 66-
plus, there was a 54.5% change from full code to no code as compared to a 0.1% change 
from no code to full code with an odds ratio for a matched pair design of OR=974 with a 
95% confidence interval (137,6921) as profiled in table 4.9.  
Table 4.8 
Code status change according to age- 18-65 
18-65 After Total 
Before Full Code No Code  
Full Code 227(24.3%) 539(57.7%) 766 
No Code 2(0.2%) 166(17.8%) 168 
Total 229 705 934 
McNemar's  p<0.0001; OR= 269 with 95% C.I. (67, 1080) 
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Table 4.9 
Code status change according to age- 66+ 
66+ After Total 
Before Full Code No Code  
Full Code 242(13.5%) 974(54.5%) 1216 
No Code 1(0.1%) 569(1.9%) 570 
Total 243 1543 1786 
McNemar's  P<0.0001; OR=  974 with 95% C.I. ( 137,6921) 
 
The intervention has both statistical significance and a clinical impact on code 
status for both the 18-65 and the 66-plus group with differences detected.   
Research Question #1d- Socioeconomic Status 
Is there a difference in code status change according to education level pre and post 
palliative intervention? 
Hypothesis Question #1d- Socioeconomic Status 
No statistical difference will be detected by education relative to code status pre and 
post palliative intervention? 
The McNemar Test to test for symmetry in change yielded a p value<.0001 for 
less than high school, high school, and college categories using only education level as a 
predictor variable for some of the categories to look at code status changes as profiled in 
tables 4.10, 4.11, and 4.12. Patients with less than high school showed the change from 
full code to no code was 55% as compared to a 0 change from no code to full code. An 
OR could not be computed because of the zero value and no confidence intervals were, 
therefore computed. In patients with a high school diploma there was a 55.7% change 
from full code to no code and a 0.2% change from no code to full code or equivalent of 
an odds ratio for a matched pair design of OR= 292 with a 95% confidence interval 
(73,1168). Among those patients with some college and beyond, there was a 51.9 % 
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change from full code to no code but a 0 change from no code to full code with an 
inability to compute odds ratio or an overall confidence interval because of the zero 
value, as profiled in table 4.12.  This analysis shows some clinical impact and 
significance. 
Table 4.10 
Code status change according to education level: less than high school 
Less than High 
School 
After Total 
Before Full Code No Code  
Full Code 68(19.4%) 193(55.0%) 261 
No Code 0 90(25.6%) 90 
Total 68 283 351 
McNemar's  p<0.0001; OR= cannot compute  with 95% C.I. (cannot compute) 
 
 Table 4.11 
Code status change according to education level: high school diploma  
High School 
Diploma 
After Total 
Before Full Code No Code  
Full Code 175(16.6%) 583(55.7%) 758 
No Code 2(0.2%) 294(27.9%) 296 
Total 177 877 1054 
McNemar's  P<0.0001; OR=  292 with 95% C.I. (73,1168) 
 
Table 4.12 
Code status change according to education level: college 
College After Total 
Before Full Code No Code  
Full Code 54(15.9%) 176(51.9% 230 
No Code 0 109(32.2%) 109 
Total 54 285 339 
McNemar's  P<0.0001; OR=  cannot compute with 95% C.I. ( cannot compute ) 
Research Question #1e- Socioeconomic Status 
Is there a difference in code status change according to income pre and post 
palliative the intervention? 
Hypothesis #1e- Socioeconomic Status 
   
66 
 
No statistical difference will be detected by income relative to code status pre and 
post palliative intervention? 
The McNemar Test to test for symmetry in change yielded a p value<.0001 for all 
income levels for those categories computed when only income was used as a predictor 
variable to look at code status changes in categories of <$10,000, $10,000-29,999, 
$30,000-49,999, $50,000-74,999 and >$75,000 as profiled in tables 4.13-4.17. No 
computations could be completed for those in categories of <$10,000, $30,000-49,999 
and $50,000-74,999 because of the 0 value which would not allow for an OR to be 
computed. Patients making $10,000-29,999 showed a change from full code to no code 
was 57.1% as compared to a 0.1% change from no code to full code with an odds ratio 
for a matched pair design of OR=392 with a 95% confidence interval (55,2790). Among 
those patients with an income > $75,000 , there was a 49.5% change from full code to no 
code as compared to a 0.2% change from no code to full code with an odds ratio for a 
matched pair design of OR=281 with a 95% confidence interval (39,2000). This analysis 
shows the intervention has clinical impact and significance. 
  
Table 4.13 
Code status change according to income- < 10,000 
Less than $10,000 After Total 
Before Full Code No Code  
Full Code 13(13.4%) 56(57.7%) 69 
No Code 0 28(28.9%) 28 
Total 13 84 97 
McNemar's  p<0.0001; OR= cannot compute with 95% C.I. ( cannot compute ) 
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Table 4.14  
Code status change according to income- 10,000-29,999 
$10,000-$29,999 After Total 
Before Full Code No Code  
Full Code 121(17.6%) 392(57.1%) 513 
No Code 1(0.1%) 173(25.2%) 174 
Total 122 565 687 
McNemar's  P<0.0001; OR= 392 with 95% C.I. (55,2790) 
 
Table 4.15  
Code status change according to income- 30,000-49,999 
$30,000-$49,999 After Total 
Before Full Code No Code  
Full Code 16(13.2%) 75(62.0%) 91 
No Code 0 30(24.8%) 30 
Total 16 105 121 
McNemar's  p<0.0001; OR= cannot compute with 95% C.I. (cannot compute ) 
 
Table 4.16  
Code status change according to income- 50,000-74,999 
$50,000-$74,999 After Total 
Before Full Code No Code  
Full Code 3(10.7%) 21(75.0%) 24 
No Code 0 4(14.3%) 4 
Total 3 25 28 
McNemar's  P<0.0001; OR= cannot compute with 95% C.I. (cannot compute ) 
 
Table 4.17 
Code status change according to income- >75,000 
$75,000 or more After Total 
Before Full Code No Code  
Full Code 87(15.3%) 281(49.5%) 368 
No Code 1(0.2%) 199(35.0%) 200 
Total 88 480 568 
McNemar's  p<0.0001; OR= 281 with 95% C.I. (39,2000) 
 
Research Question #1f- Socioeconomic Status 
Is there a difference in code status change according to payer source pre and post 
palliative intervention? 
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Hypothesis #1f 
No statistical difference will be detected by payer source relative to code status pre 
and post palliative intervention? 
The McNemar Test to test for symmetry in change using a p value<.0001 was 
used for both underinsured and insured with only payer source as a predictor variable to 
look at code status changes between the insured and the underinsured as profiled in tables 
4.18 and 4.19. This showed change from full code to no code was 54.3% as compared to 
a 0.1% change from no code to full code in the insured with an odds ratio for a matched 
pair design of OR=631 with a 95% confidence interval (158,2526). Among the 
underinsured, there was a 60.2% change from full code to no code as compared to a 0.2% 
change from no code to full code with an  odds ratio for a matched pair design of 
OR=313 with a 95% confidence interval (44,2229)  as profiled in table 4.19. The 
intervention has both a statistically significant yield and a clinical impact on code status 
for both the insured and the underinsured with difference detected.   
Table 4.18 
Code status change according to payer source- insured 
Insured After Total 
Before Full Code No Code  
Full Code 378(16.3%) 1262(54.3%) 1640 
No Code 2(0.1%) 681(29.3%) 683 
Total 380 1943 2323 
McNemar's  P<0.0001; OR= 631 with 95% C.I. ( 158, 2526) 
 
Table 4.19 
Code status change according to payer source- underinsured 
Underinsured After Total 
Before Full Code No Code  
Full Code 118(22.7%) 313(60.2%) 431 
No Code 1(0.2%) 88(16.9%) 89 
Total 119 401 520 
McNemar's  P<0.0001; OR=313 with 95% C.I. (44, 2229) 
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Research Question #1g 
Is there a difference in code status change according to disease distribution pre and 
post and palliative intervention? 
Hypothesis #1g 
No statistical difference will be detected by disease distribution relative to code 
status pre and post palliative intervention?  
The McNemar Test to test for symmetry in change using a p value<.0001 for 
those with and without cancer  with only disease distribution as a predictor variable to 
look at code status changes between those patients with cancer and those without cancer 
as profiled in tables 4.20 and 4.21.  This showed change from full code to no code was 
57.9% as compared to a 0 change from no code to full code in females with an odds ratio 
for a matched pair design where the OR could not be computed and thus the confidence 
interval could not be computed. Among those patients without cancer, there was a 55.3% 
change from full code to no code as compared to a 0.1% change from no code to full 
code with an odds ratio for a matched pair design of OR=550 with a 95% confidence 
interval (137,2201)  as profiled in table 4.21.  
Table 4.20  
Code status change according to disease distribution: cancer 
Cancer After Total 
Before Full Code No Code  
Full Code 117(18.3%) 371(57.9%) 488 
No Code 0 153(23.9%) 153 
Total 117 524 641 
McNemar's  P<0.0001; OR= cannot compute with 95% C.I. (cannot compute) 
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Table 4.21 
Code status change according to disease distribution: no cancer  
Non-Cancer After Total 
Before Full Code No Code  
Full Code 337(16.9%) 1100(55.3%) 1437 
No Code 2(0.1%) 550(27.7%) 552 
Total 339 1650 1989 
McNemar's  P<0.0001; OR=550 with 95% C.I. (137,2201) 
A model of final code status based on possible predictors was used through the 
Logistic Regression Test analysis profiled in table 4.22. The model was used to predict 
the Logit of having a full code status after the intervention. The initial model used the 
predictor variables: prior code status, race, age, gender, education, income, and payer 
source.  
Table 4.22 
Code status  
 Logistic Regression Model for predicting Full Code  
Variable Coefficient Standard Error P-value 
Prior Code Status 4.072 0.714 <0.001 
Race 0.609 0.195 0.002 
Age -0.602 0.169 <0.001 
Gender -0.098 0.152 0.520 
Education (multiple 
coefficients) 
 0.892 
Income (multiple 
coefficients) 
 0.048 
Pay Source -0.215 0.204 0.292 
Constant -5.559 0.822 <0.001 
    
Prior Code Status  
(full code is 
reference) 
4.001 0.582 <0.001 
Race (black is 
reference) 
0.529 0.119 0.002 
Age (66 and older 
is reference) 
-0.512 0.119 <0.001 
Constant -5.217 0.587 <0.001 
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The test yielded Black, full code prior and over 66 for a Logit of full code 
resulting in odds ratio of 0.301. The test yielded Black, full code, and aged 18-65 for a 
Logit of full code equaling odds ratio of 0.503.  
Combining the results of both yields, the odds ratio of a full code for a person 
ages 18-65 to a person aged 66-plus with everything else being equal is 1.67. Younger 
people are more likely to have a full code as opposed to older people.  Further, Blacks 
have higher odds of a full code status than Whites and those with a prior full code status 
have higher odds of a final full status than those with a no code.  
Research Question #2 
Is there a difference in Stage IV, (comfort measures status) pre and post palliative 
intervention? 
Hypothesis #2 
No statistical differences will be detected relative to comfort measures status pre 
and post palliative intervention? 
The McNemar Test to test for symmetry in matched pairs yielding a p 
value<.0001 for the total patient population to look at care level changes between comfort 
and aggressive measures, as profiled in table 4.23, showed change from aggressive to 
comfort was 39% as compared to a 0.2% change from comfort to aggressive with an odds 
ratio for a matched pair design of OR=185 with a 95% confidence interval (83,412).  The 
intervention has both statistical significance and has a clinical impact on care level status 
as resulting comfort measures are 185 times more likely than resulting aggressive 
measures.   
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Table 4.23 
Aggressive/Comfort measure changes- total population 
 After Total 
Before Aggressive Comfort only  
Aggressive 1605(56.5%) 1108(39.0%) 2713 
Comfort only 6(0.2%) 124(4.4%) 130 
Total 1611 1232 2843 
McNemar's p-value <0.0001; OR= 185 with 95% C.I. ( 83, 412)   
Research Question #2a 
Is there a difference in Stage IV, (comfort measures status) according to gender pre 
and post palliative intervention? 
Hypothesis #2a 
No statistical differences will be detected by gender relative to comfort measures 
status pre and post palliative intervention? 
The McNemar Test to test for symmetry in matched pairs using a p value<.0001 
for both females and males was used with only gender as a predictor variable to look at 
care level changes between comfort and aggressive measures as profiled in tables 4.24 
and 4.25. This showed a change in females from aggressive to comfort measures was 
39.2% as compared to a 0.3% change from comfort to aggressive with an odds ratio for a 
matched pair design of OR= 145 with a 95% confidence interval (54,386). Among males, 
there was a 38.7% change from aggressive to comfort measure status as compared to a 
0.1% change from comfort to aggressive measures with an odds ratio for a matched pair 
design of OR=263 with a 95% confidence interval (66,1056).  The intervention has both 
statistical significance and a clinical impact on care level status for both females and 
males with slight differences detected.   
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Table 4.24  
Aggressive/Comfort measure change based on gender- female 
Female After Total 
Before Aggressive Comfort only  
Aggressive 820(55.7%) 578(39.2%) 1398 
Comfort only 4(0.3%) 71(4.8%) 75 
Total 824 649 1473 
McNemar's  p<0.0001; OR= 145 with 95% C.I. (54, 386) 
 
Table 4.25 
Aggressive/Comfort measures change based on gender- male 
Male After Total 
Before Aggressive Comfort only  
Aggressive 780(57.3% 527(38.7%) 1307 
Comfort only 2(0.1%) 53(3.9%) 55 
Total 782 580 1362 
McNemar's  P<0.0001; OR= 263 with 95% C.I. (66, 1056) 
Research Question #2b 
Is there a difference in Stage IV, (comfort measures status) according to race pre 
and post palliative intervention? 
Hypothesis #2b 
No statistical differences will be detected by race relative to comfort measures status 
pre and post palliative intervention? 
The McNemar Test to test for symmetry in matched pairs using a p value<.0001 
for both race categories was used with only race as a predictor variable to look at care 
level changes between comfort and aggressive measures as profiled in tables 4.26 and 
4.27. This showed a change from aggressive to comfort in Blacks was 31.4% as 
compared to a 0.2% change from comfort to aggressive measures with an odds ratio for a 
matched pair design of OR=157 with a 95% confidence interval (39,629). Among 
Whites, there was a 44.4% change from aggressive to comfort care as compared to a 
0.1% change from comfort to aggressive care with an odds ratio for a matched pair 
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design of OR=318 with a 95% confidence interval (79,1274).  The intervention has both a 
statistically significant yield and a clinical impact on care level status for both Black and 
Whites, and with significant difference detected.   
 
Table 4.26  
Aggressive/Comfort measure status by race- Black 
Black After Total 
Before Aggressive Comfort only  
Aggressive 648(65.1%) 313(31.4% 961 
Comfort only 2(0.2%) 33(3.3%) 35 
Total 650 346 996 
McNemar's  p<0.0001; OR= 157 with 95% C.I. (39, 629) 
 
Table 4.27 
Aggressive/Comfort measure status by race- White 
White After Total 
Before Aggressive Comfort only  
Aggressive 725(50.6%) 636(44.4%) 1361 
Comfort only 2(0.1%) 69(4.8%) 71 
Total 727 705 1432 
McNemar's  P<0.0001; OR= 318 with 95% C.I. (79, 1274) 
Research Question #2c 
Is there a difference in Stage IV, (comfort measures status) according to age pre and 
post palliative intervention? 
Hypothesis #2c 
No statistical differences will be detected by age relative to comfort measures status 
pre and post palliative intervention? 
The McNemar Test to test for symmetry in matched pairs using a p value<.0001 
was used with only age as a predictor variable for both age groups to look at care level 
changes between comfort and aggressive measures as profiled in tables 4.28 and 4.29. 
Those aged 18-65 showed change from aggressive to comfort status was 36% as 
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compared to a 0.1% change from comfort to aggressive with an odds ratio for a matched 
pair design of OR=336 with a 95% confidence interval (47,2392). Among those aged 
66+, there was a 41.4% change from aggressive to comfort care as compared to a 0.2% 
change from comfort to aggressive care with an odds ratio for a matched pair design of 
OR=185 with a 95% confidence interval (65,494).  The intervention has both a 
statistically significant yield and a clinical impact on care level status for both age 
groups, and with significant differences detected.   
 
Table 4.28 
Aggressive/ Comfort measure status by age-18-65 
18-65 After Total 
Before Aggressive Comfort only  
Aggressive 575(61.6%0 336(36.0%) 911 
Comfort only 1(0.1%) 22(2.4%) 23 
Total 576 358 934 
McNemar's  p<0.0001; OR= 336 with 95% C.I. (47, 2392) 
 
Table 4.29  
Aggressive/Comfort measure status by age-66+ 
66+ After Total 
Before Aggressive Comfort only  
Aggressive 950(53.2%) 739(41.4%) 1689 
Comfort only 4(0.2%) 93(5.2%) 97 
Total 954 832 1786 
McNemar's  P<0.0001; OR=  185 with 95% C.I. (69, 494) 
Research Question #2d- socioeconomic status 
Is there a difference in Stage IV, (comfort measures status) according to education 
level pre and post palliative intervention? 
Hypothesis #2d 
No statistical differences will be detected by education level relative to comfort 
measures status pre and post palliative intervention? 
   
76 
 
The McNemar Test to test for symmetry in matched pairs using a p value<.0001 
was used for all education levels with only education as a predictor variable to look at 
care level changes between comfort and aggressive measures as profiled in tables 4.30, 
4.31 and 4.32. For those in the less than high school category, a 31.3% change showed 
from aggressive to comfort measures. There was a zero for the measure from comfort to 
aggressive so no OR or confidence interval computation could be conducted. Those with 
a high school diploma showed a change from aggressive to comfort at  41.8% as 
compared to a 0.3% change from comfort to aggressive in with an  odds ratio for a 
matched pair design of OR=147 with a 95% confidence interval (47,58). Among those 
patients with some college education and beyond, there was a 41% change from 
aggressive to comfort measures as compared to a 0.6% change from comfort to 
aggressive care with an odds ratio for a matched pair design at OR= 70 with a 95% 
confidence interval (17,281).   
 
Table 4.30  
Aggressive/Comfort measure status by education level- less than high school 
Less than H.S. After Total 
Before Aggressive Comfort only  
Aggressive 227 110(31.3%) 337 
Comfort only 0 14(4.0%) 14 
Total 227 124 351 
McNemar's  p<0.0001; OR= cannot compute with 95% C.I. (cannot compute) 
 
Table 4.31 
Aggressive/Comfort measure status by education level- high school diploma 
H.S. Diploma After Total 
Before Aggressive Comfort only  
Aggressive 563 441(41.8%) 1004 
Comfort only 3(0.3%) 47(4.5%) 50 
Total 566 488 1054 
McNemar's  P<0.0001; OR=  147 with 95% C.I. (47,458) 
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Table 4.32 
Aggressive/Comfort measures status by education level- college 
College After Total 
Before Aggressive Comfort only  
Aggressive 179(52.8%) 139(41.0%) 318 
Comfort only 2(0.6%) 19(5.6%) 21 
Total 181 158 339 
McNemar's  P<0.0001; OR=  70 with 95% C.I. (17,281) 
This shows that there was some significance when comparing education levels, 
while others produced no significance at all. A comparison could therefore not be made 
between all three education variables. 
Research Question #2e- socioeconomic status 
Is there a difference in Stage IV, (comfort measures status) according to income pre 
and post palliative intervention? 
Hypothesis #2e 
No statistical differences will be detected by income relative to comfort measures 
status pre and post palliative intervention? 
The McNemar Test to test for symmetry in matched pairs using a p value<.0001 
for income categories and with only income as a predictor variable to look at care level 
changes between comfort and aggressive measures as profiled in tables 4.33-4.37, 
showed change from aggressive to comfort was 29.9% as compared to a 1.0% change 
from comfort to aggressive in patients with income <$10,000 with an odds ratio for a 
matched pair design of OR=29 with a 95% confidence interval (4,213). For those in the 
income level ranging from $10,000-29,999, a computation could not be made. Patients 
with income from the $30,000-49,999 showed change from aggressive to comfort was at 
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47.1% as compared to a 0.8% change from comfort to aggressive with an odds ratio for a 
matched pair design of OR=57 with a 95% confidence interval (8,425).   
Those in the $50,000-74,999 income range could not be computed because of 
zero value in comfort to aggressive. Lastly, those patients making >$75,000 showed a 
change from aggressive to comfort was 41% as compared to a 0.2% change from comfort 
to aggressive with an odds ratio for a matched pair design of OR= 223 with a 95% 
confidence interval (31,1590).  
 
Table 4.33  
Aggressive/Comfort Measure Status by income <$10,000 
Less than $10,000 After Total 
Before Aggressive Comfort only  
Aggressive 29(29.9%) 29(29.9%) 58 
Comfort only 1(1.0%) 4(4.1%) 4 
Total 30 33 63 
McNemar's  p<0.0001; OR= 29 with 95% C.I. (4, 213) 
 
Table 4.34  
Aggressive/Comfort measure Status by income-10,000-29,999 
$10,000-$29,999 After Total 
Before Aggressive Comfort only  
Aggressive 399(58.1%) 261(38.0%) 660 
Comfort only 0 27(3.9%) 27 
Total 399 288 687 
McNemar's  P<0.0001; OR= cannot compute with 95% C.I. (cannot compute ) 
 
Table 4.35  
Aggressive/Comfort measure status by income- 30,000-49,999 
$30,000-$49,999 After Total 
Before Aggressive Comfort only  
Aggressive 58(47.9%) 57(47.1%) 115 
Comfort only 1(0.8%) 5(4.1%) 6 
Total 59 62 121 
McNemar's  p<0.0001; OR= 57 with 95% C.I. (8,425) 
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Table 4.36  
Aggressive/Comfort measure status by income- 50,000-74,999 
$50,000-$74,999 After Total 
Before Aggressive Comfort only  
Aggressive 15(53.6%) 12(42.9%) 27 
Comfort only 0 1(3.6%) 1 
Total 15 13  
McNemar's  P<0.0001; OR= cannot compute with 95% C.I. (cannot compute) 
 
Table 4.37  
Aggressive/Comfort measure status by income- >75,000 
$75,000 or more After Total 
Before Aggressive Comfort only  
Aggressive 306(53.9%) 223(41.0%) 529 
Comfort only 1(0.2%) 28(4.9%) 29 
Total 307 251 558 
McNemar's  p<0.0001; OR= 223 with 95% C.I. (31, 1590) 
Research Question #2f 
Is there a difference in Stage IV, (comfort measures status) according to payer 
source pre and post palliative intervention? 
Hypothesis #2f 
No statistical differences will be detected by payer source relative to comfort 
measures status pre and post palliative intervention? 
The McNemar Test to test for symmetry in matched pairs using a p value<.0001 
for both insured and underinsured was used with only payer source as a predictor variable 
to look at care level changes between comfort and aggressive measures as profiled in 
tables 4.38 and 4.39. The insured population showed a change from aggressive to comfort 
was 38.4 % as compared to a 0.1% change from comfort to aggressive with an odds ratio 
for a matched pair design of OR= 298 with a 95% confidence interval (96,925). Among 
the underinsured, there was a 41.3% change from aggressive to comfort measures as 
compared to a 0.6% change from comfort to aggressive care with an odds ratio for a 
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matched pair design of OR=72 with a 95% confidence interval (23,224).  The 
intervention has both a statistically significant impact and a clinical impact on code status 
for both the insured and underinsured with no difference detected.   
 
Table 4.38  
Aggressive/Comfort measure status by payer source -insured 
Insured After Total 
Before Aggressive Comfort only  
Aggressive 1311(56.4%) 893(38.4%) 2204 
Comfort only 3(0.1%) 116(5.0%) 119 
Total 1314 1009 2323 
McNemar's  P<0.0001; OR= 298 with 95% C.I. (96,925) 
 
Table 4.39:  
Aggressive/Comfort measure status by payer source- underinsured 
Underinsured After Total 
Before Aggressive Comfort only  
Aggressive 294(56.5) 215(41.3%) 509 
Comfort only 3(0.6%) 8(1.5%) 11 
Total 297 223 520 
McNemar's  P<0.0001; OR=72 with 95% C.I (23, 224) 
Research Question #2g 
Is there a difference in Stage IV, (comfort measures status) according to disease 
distribution pre and post palliative intervention? 
Hypothesis #2g 
No statistical differences will be detected by disease relative to comfort measures 
status pre and post palliative intervention? 
The McNemar Test to test for symmetry in matched pairs using a p value<.0001 
for both categories was used with only disease as a predictor variable to look at care level 
changes between comfort and aggressive measures as profiled in tables 4.40 and 4.41.  
Patients with cancer showed a change from aggressive to comfort measures at 36% as 
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compared to a 0.2% change from comfort to aggressive with an odds ratio for a matched 
pair design of OR=231 with a 95% confidence interval (32,1647). Among those without 
cancer, there was a 40.8% change from aggressive to comfort as compared to a 0.3% 
change from comfort to aggressive measures with an odds ratio for a matched pair design 
of OR=162 with a 95% confidence interval (67,391).  The intervention has both statistical 
significance and a clinical impact on code status for those patients with cancer and those 
with other primary conditions with limited differences detected.   
 
Table 4.40  
Aggressive/ comfort status for disease distribution-cancer 
Cancer After Total 
Before Aggressive Comfort only  
Aggressive 385(60.1%) 231(36.0%) 616 
Comfort only 1(0.2%) 24(3.7%) 25 
Total 386 255 641 
McNemar's  P<0.0001; OR= 231 with 95% C.I. ( 32, 1647) 
 
Table 4.41 
Aggressive/comfort status for disease distribution-no cancer 
Non-Cancer After Total 
Before Aggressive Comfort only  
Aggressive 1087(54.7) 812(40.8%)  
Comfort only 5(0.3%) 85(4.3%)  
Total 1092 897  
McNemar's  P<0.0001; OR=162 with 95% C.I. (67, 391) 
A model of final comfort status based on possible predictors using Logistic 
Regression shown below in tables 4.42. The model was used to predict the Logit of 
having an aggressive care status after the intervention. Using the initial model with the 
predictor variables: prior comfort status, race, age, gender, education, income, and payer 
source, the analysis yielded the following results: The Logit for Blacks with less than 
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high school and prior aggressive care is computed to an odds of 2.42. For Whites with 
less than high school and prior aggressive care the odds are 1.57.  The odds ratio is 1.54. 
Therefore, the odds of having a Black patient with aggressive care and less than a 
high school education is 54% greater than that of a White patient with the same education 
and prior aggressive care. A White patient in the same level is more than 50% more 
likely to have comfort measure status. Based on multiple full model-reduced model 
fittings and tests, the best final model is summarized below in table 4.42 with less than 
high school as the reference.  
 
Table 4.42 
Aggressive/ Comfort measures Status- multiple variables 
 Logistic Regression Model for predicting Aggressive Care  
Variable Coefficient Standard Error P-value 
Prior care 3.412 0.596 <0.001 
Race 0.488 0.139 <0.001 
Age -0.242 0.130 0.063 
Gender 0.130 0.111 0.240 
Education (multiple 
coefficients) 
 0.020 
Income (multiple 
coefficients) 
 0.158 
Pay Source -0.244 0.161 0.130 
Constant -2.587 0.663 <0.001 
 
Prior Comfort 
(Aggressive Care) 
 
 
3.444 
 
 
0.594 
 
 
<0.001 
Race (black is 
reference) 
0.431 0.115 <0.001 
Education (HS 
diploma) 
-0.384 0.148 0.009 
Education 
(College) 
-0.256 0.183 0.163 
Constant -2.991 0.606 <0.001 
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Research Question 3a, 3c, 3f  
Is there a difference in Hospice discharge according to (a)gender, (c)age (f)payer 
source following a palliative care intervention? 
Hypothesis #3a 
No statistical differences will be detected relative to (a)gender, (c)age, (f)payer 
source for hospice discharge following the palliative intervention? 
The Likelihood Ratio Chi-Square Test was used to measure outcome differences 
relative to hospice discharge. The likelihood function was first used to determine the best 
model and to determine the parameters of the chi-square. Many of the demographic 
variables produced no significant results relative to hospice discharge. When measuring 
gender differences, as profiled in table 4.43, p=0.131 there was no significance shown. 
When measuring age difference as profiled in table 4.44, p=0.757, with no significant 
difference between those aged 18-65 and those aged 66-plus. When measuring pay 
source profiled in table 4.45, p=0.311, with no significant differences in the insured and 
underinsured with respect to hospice discharge. Thus, we fail to reject the null for these 
research questions.   
 
Table 4.43 
Hospice discharge according to gender 
 Hospice Discharge 
Gender Used Hospice 
after 
discharge 
No Hospice Died in 
Hospital * 
hospice in 
hospital 
Total 
Female 243(18.7%) 269(20.7%) 785(60.5%) 1297(100.0%) 
Male 247(20.8%) 212(17.9%) 727(61.3%) 1186(100.0%) 
Total 490 481 1512 2483 
Likelihood Ratio Chi-Square = 4.065 with 2 df, p=0.131 No significant difference in hospice with respect 
to gender. 
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Table 4.44 
Hospice discharge according to age 
 Hospice Discharge 
Age Used Hospice 
after 
discharge 
No Hospice Died in 
Hospital * 
hospice in 
hospital 
Total 
18-65 154(19.1%) 153(18.9%) 501(62.0%) 808(100.0%) 
66 and older 317(20.1%) 305(19.4%) 953(60.5%) 1575(100.0%) 
Total 471 458 1454 2383 
Likelihood Ratio Chi-Square = 0.557 with 2 df, p=0.757 No significant difference in hospice with respect 
to age. 
 
Table 4.45 
Hospice discharge according to pay source 
 Hospice Discharge 
Pay Source Used Hospice 
after 
discharge 
No Hospice Died in 
Hospital * 
hospice in 
hospital 
Total 
Insured 413(20.3%) 395(19.4% 1224(60.2%) 2032(100%) 
Underinsured 80(17.5%) 86(18.8%) 291(63.7%) 457(100%) 
Total 493 481 1515 2489 
Likelihood Ratio Chi-Square = 2.337 with 2 df, p=0.311 No significant difference in hospice with respect 
to Pay Source 
Research Question #3b 
Is there a difference in Hospice discharge according to race following a palliative 
care intervention? 
Hypothesis #3b 
No statistical differences will be detected relative to race for hospice discharge 
following the palliative intervention? 
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 When measuring for differences in hospice rate of discharge with respect to race, 
the Likelihood Ratio Chi-Square Test yielded p<.001, which is statistically significant 
indicating that Blacks are less likely than Whites to use hospice services as profiled in 
table 4.46.  
 
Table 4.46 
Hospice discharge according to race 
 Hospice Discharge 
Race Used Hospice 
after 
discharge 
No Hospice Died in 
Hospital * 
hospice in 
hospital 
Total 
Black 172(19.4%) 218(24.6%) 495(55.9%) 885(100.0%) 
White 228(18.4%) 166(13.4%) 845(68.2%) 1239(100.0%) 
Total 400 384 1340 2124 
Likelihood Ratio Chi-Square = 48.140 with 2 df, p<0.001  
Research Question #3d 
Is there a difference in Hospice discharge according to socioeconomic status- 
education level following a palliative care intervention? 
Hypothesis #3d 
No statistical differences will be detected by socioeconomic status- education level 
hospice discharge following the palliative intervention? 
 For those patients measured by education level, table 4.47 presents data to profile 
the results of the Likelihood Chi-Square analysis in comparing patients and education 
level. The test yielded a p=0.010. This shows that there was significant difference among 
those patients with less than high school, indicating a higher likelihood for no hospice for 
these patients.   
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Table 4.47  
Hospice discharge according to education 
 Hospice Discharge 
Education Used Hospice 
after 
discharge 
No Hospice Died in 
Hospital * 
hospice in 
hospital 
Total 
Less than HS 76(24.9%) 74(24.3%) 155(50.8%) 305(100.0%) 
HS Diploma 187(19.8%) 174(18.4%) 584(61.8%) 945(100.0%) 
College 54(19.4%) 48(17.3%) 176(63.3%) 278(100.0%) 
Total 317 296 915 1528 
Likelihood Ratio Chi-Square = 13.187 with 4 df, p=0.010  
Research Question #3e -  
Is there a difference in hospice discharge according to socioeconomic status-income 
following a palliative care intervention? 
Hypothesis #3e 
No statistical differences will be detected by socioeconomic discharge-income 
relative to hospice discharge following the palliative intervention? 
For the income variable comparison relative to hospice discharge, table 4.48 
profiles the results of the Likelihood Ratio Chi-Square analysis. 
 
Table 4.48 
Hospice discharge according to income 
 Hospice Discharge 
Income Used Hospice 
after 
discharge 
No Hospice Died in 
Hospital * 
hospice in 
hospital 
Total 
Less than 
10,000 
14(15.9%) 20(22.7%) 54(61.4%) 88(100%) 
10,000-29,999 115(19.0%) 135(22.3%) 356(58.7%) 606(100%) 
30,000-49,999 17(17.2%) 15(15.2%) 67(67.7%) 99(100%) 
50,000-74,999 7(25.9%) 4(14.8%) 16(59.3%) 27(100%) 
75,000 or 
more 
100(20.3%) 68(13.8%) 324(65.9%) 492(100%) 
Total 253 242 817 1312 
Likelihood Ratio Chi-Square = 16.794 with 8 df, p=0.032  
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The test is comparing those with lower income levels to those with higher 
incomes. The test yields a p=0.032. This shows a significant difference with respect to 
income. As income goes up, the percentage for no hospice decreases. 
Research Question 3g  
Is there a difference in Hospice discharge according to disease following a palliative 
care  intervention? 
Hypothesis #3g 
No statistical differences will be detected relative to disease for hospice discharge 
following the palliative intervention 
Using the Likelihood Ratio Chi-Square as profiled in table 4.49, cancer patients 
were compared to non-cancer patients. The test yielded a p<.001 showing a higher 
number of cancer patients used hospice care. This indicated significance.  
 
Table 4.49  
Hospice discharge according to disease distribution 
 Distribution of Disease 
Hospice D/C Cancer Not Cancer Total 
Used  Hospice 
after discharge 
157(34.6%) 297(65.4%) 454 
No Hospice 97(21.9%) 346(78.1%) 443(100%) 
Died in Hospital * 
hospice in hospital 
314(22.3%) 1091(77.7%) 1405 
Total 568 1734 2302 
Likelihood Ratio Chi-Square = 29.904 with 2 df, p<0.001.    
 For the purpose of measuring the intervention’s impact and differences in variable 
groups according to cost, length of stay and days saved were used as measurement tools. 
For the length of stay analysis, the McNemar-Bowker test of symmetry was used. To 
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analyze the days saved measurement of cost, both the t-test and the Anova and 
Bonferroni were used as profiled in the tables below. 
Research Question #4 
Is there a difference in cost per length of stay pre and post palliative care 
intervention? 
Hypothesis #4 
No statistical differences will be detected relative to cost per length of stay pre and 
post palliative intervention 
 For the total population of patients, length of stay categories were measured using 
the McNemar-Bowker test of symmetry. Table 4.50 profiles data to show significance in 
the decrease of length of stay post intervention. The test yielded a p-value<0.001, 
showing  a lack of symmetry in the distribution of changes and significance. The 
decrease overall occurs in category 7-14 days with a change from 15.5% to 10.0%, in the 
category of 15-21 days the change was 3.3% to 1.2% and in >21 days a decrease from 
8.6% to 1.4%. 
 
Table 4.50  
Length of stay  
% is of 
total 
LOS after PCC 
LOS 
before 
PCC 
0-6 days 7-14 days 15-21 days > 21 days Total 
0-6 days 1275(49.3%) 259(10.0%) 31(1.2%) 36(1.4%) 1601(61.9%) 
7-14 days 402(15.5%) 74(2.9%) 20(0.8%) 29(1.1%) 525(20.3%) 
15-21 days 85(3.3%) 23(0.9%) 5(0.2%) 8(0.3%) 121(4.7%) 
> 21 days 222(8.6%) 60(2.3%) 19(0.7%) 39(1.5%) 340(13.1%) 
Total 1984(76.7%) 416(16.1%) 75(2.9%) 112(4.3%) 2587(100%) 
McNemar-Bowker test of symmetry statistic is 205.656 with 6 df and p<0.001.   
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Research Question #4a, 4b, 4c, 4d, 4e, 4f, 4g 
Is there a difference in cost per length of stay pre and post palliative care 
intervention? 
Hypothesis #4a, 4b, 4c, 4d, 4e, 4f, 4g 
No statistical differences will be detected relative to cost per length of stay pre and 
post palliative intervention 
 As stated above, length of stay could not be computed in 2-by-2 tables for each 
variable analysis, or further for a multivariate analysis. Therefore, we cannot accept nor 
fail to reject the null. 
Research Question #5   
Is there a difference in cost per days saved following a palliative care intervention? 
Hypothesis #5 
No statistical differences will be detected relative to cost per days saved following 
palliative intervention? 
 The overall days saved mean=3.68 with a standard deviation=4.05 for N=2843. 
The t-test analysis showed no significant differences with respect to gender, race, pay 
source, education or income, indicating the null hypothesis was accepted for variables of 
race and socioeconomic status, age and gender with respect to cost. However, 
significance was found with variables of age profiled in table 4.51, in disease distribution 
profiled in table 4.52, and in hospice discharge profiled in table 4.53 below. 
Research Question #5a, 5b, 5d, 5e, 5f   
Is there a difference in cost per days saved following a palliative care intervention? 
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Hypothesis #5a, 5b, 5d, 5e, 5f 
No statistical differences will be detected relative to cost per days saved following 
palliative intervention 
 Again, no significance was found with respect to gender, race, education, income, 
or payer source. Therefore, we fail to reject the null. 
Research Question #5c   
Is there a difference in cost per days saved by age following a palliative care 
intervention? 
Hypothesis #5c 
No statistical differences will be detected by age relative to cost per days saved 
following palliative intervention 
 Using age as a lone predictor variable for days saved, the t-test analysis yielded a 
p-value=0.036 profiled in table 4.51 with a difference of .35 days between ages 18-65 
and those aged 66+. This indicated significance and a clinical cost impact post 
intervention. The patients aged 18-65 had a higher mean for days saved. 
 
Table 4.51 
Days saved according to age 
Age N Mean Standard 
deviation 
t-statistic 
(df) 
p-value 
18-65 934 3.93 4.73 2.104(2718) 0.036 
66 and 
older 
1786 3.58 3.65   
There is a significant difference and it is .35 days per 18-65 year old person 
Research Question #5g   
Is there a difference in cost per days saved by disease following a palliative care 
intervention? 
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Hypothesis #5g 
No statistical differences will be detected relative to cost per days saved by disease 
following palliative intervention? 
Using disease distribution as a lone predictor variable for days saved, the t-test 
analysis yielded a p-value=.002 with a .59 difference between those with cancer and 
those with no cancer, profiled in table 4.52.  
This indicated significance and a clinical cost impact. The non-cancer patients had 
a higher mean of days saved. 
 
Table 4.52 
Days saved according to disease distribution 
Age N Mean Standard 
deviation 
t-statistic 
(df) 
p-value 
Cancer 641 3.28 3.39 -3.133(2628) 0.002 
Not Cancer 1989 3.87 4.30   
There is a significant difference and it is .59 days per non-cancer person 
Research Question #5h   
Is there a difference in cost per days saved by a hospice population following a 
palliative care intervention? 
Hypothesis #5h 
No statistical differences will be detected relative to cost per days saved by hospice 
population following palliative intervention? 
Using only discharge to hospice as a variable for days saved the Anova and 
Bonferri test yielded a p-value<0.001, which is statistically significant. Bonferri 
adjustments to the cell means were made profiled in table 4.53.  
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Table 4.53  
Days saved according to hospice status 
Hospice D/C N Mean Standard 
deviation 
F-statistic p-value 
Used hospice 
after discharge 
493 3.69b 3.73 58.997 <0.001 
No hospice 481 2.02a 3.26   
Died in 
Hospital * 
hospice in 
hospital 
1515 4.29c 4.09   
There is a statistically significant result with p<0.001.  Bonferroni adjustments to the cell means were 
made and the letters next to the means indicate the difference.  Means with the same letters are not 
different 
Systematic Sample 
 In addition to the analysis above, a ten percent systematic sample was selected to 
determine if there were cost savings in dollars as a result of the palliative intervention. 
The Principal Investigator did not use the total patient population because of privacy 
constraints and access stipulations placed by the Medical Center. To extract cost data in 
an objective way which upheld the regulations and efficiency constraints placed by both 
MCCG and the Georgia Southern University Institutional Review Board, the cost data 
had to be taken directly from the record by an objective third party. A financial audit then 
took place by an objective third party for each random patient chosen. The information 
extracted gave the costs per day pre and post palliative intervention. A difference was 
then taken from both categories and the average mean of the days before and after the 
intervention along with the average mean difference was calculated as profiled in table 
4.54.  
To achieve the sample, a unique identifier called “patient one” was randomly 
selected and from there, every tenth patient became part of this systematic sample. The 
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total random sampling process resulted in approximately 10% of the total patient 
population, or n=292. 
The mean cost per day prior to a palliative intervention was $2,229.46. The mean 
cost per day following the palliative intervention was $731.17. The mean difference in 
cost per day was $1,498.29. This systematic random sample showed that $1,498.29 per 
day was saved after a palliative intervention occurred.  
 To conduct the cost analysis, adjustments were made for twenty-six patients with 
missing data, equaling 9.3% of the randomly chosen population. It should also be stated 
that there was a $0.00 amount following the intervention for forty-seven of the patients 
randomly chosen. This was probably a result of withdrawal of all care and subsequent 
death following the intervention, or a result of immediate discharge from the hospital to a 
hospice facility following the intervention. It does not skew analysis to include the $0.00 
patients because the intervention was the means to the withdrawal or the discharge.  
 
Table 4.54  
Cost savings average pre and post intervention: random sample n=292 
Before After                                      Difference     
$2229.46 $731.17 $1498.29 
Summary of Results 
 In summary, the data showed significant findings. The McNemar test of 
symmetry in code status revealed six significant findings when using lone predictor 
variables to look at change in code status pre and post palliative intervention, rejecting 
Hypotheses #1, #1a, #1b, #1c, #1e, and #1f outright. For Hypotheses #1d and #1g, one 
category showed difference but others could not be computed resulting in the inability to 
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reject or to fail to reject the null. The multivariate analysis concluded that specific 
differences were found when looking at race and age. Both younger people and Blacks 
were more likely to stay full code. The McNemar test of symmetry in aggressive and 
comfort measures also yielded six significant findings and rejected Hypothesis #2, #2a, 
#2b, #2c, #2f, and #2g. Hypothesis #2d and #2e could neither be accepted nor rejected 
because of the inability to compute all categories. Specific differences were found when 
looking at race and socioeconomic status in the same analysis. The multivariate analysis 
for comfort and aggressive measures showed that Blacks with a less than high school 
education were more likely to choose aggressive measures than Whites with the same 
education level.  
The Likelihood Ratio Chi-Square Test relative to hospice discharge revealed four 
significant findings, rejecting Hypotheses #3b, #3d, #3e and #3g and failing to reject #3a, 
#3c, and 3f. The overall findings suggest that Blacks are less likely to use hospice. Those 
with lower income are more likely to choose “no hospice” and cancer patients are more 
likely to use hospice. Specific differences were found when looking at race and 
socioeconomic status.  
The McNemar-Bowker test of symmetry to test for costs saved by length of stay 
showed significant decrease in overall costs, rejecting Hypothesis #4.  However, due to 
the complexity of the variables, there was no known current test to compare other 
predictor variables and Hypotheses #4a- #4g could neither be proven or disproven. Both 
the t-test and ANOVA Bonferroni showed five significant findings comparing days saved 
as a cost measure and rejected Hypotheses #5, #5c, #5e, #5g and #5h. However, no 
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differences were found relative to gender, race or socioeconomic status, failing to reject 
Hypothesis #5a, #5b, #5d, #5e, and #5f. 
 In summary of the data analysis, it appears that the palliative intervention showed 
significant differences in change of treatment level choices and significant cost reduction 
overall.  It also appears that there are some significant differences dependent upon 
variables of age, race, disease and socioeconomic status. 
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CHAPTER 5 
SUMMARY, DISCUSSION, AND CONCLUSIONS 
The purpose of this study was to examine differences in treatment level at the end 
of life according to socioeconomic status and race.  The intent is to provide a better 
understanding of population differences in treatment level preferences at the end of life 
and further understanding of the palliative intervention. 
This final chapter is organized into the sections listed below which pertain to the 
relevant discussion, conclusions, and implications of this study: (1) summary of findings; 
(2) conclusions; (3) discussion; (4) strengths and limitations; (5) implications for public 
health; and finally (6) suggestions for future research. 
Summary of Findings 
This study represented a large patient population in both rural and suburban 
Georgia. A sample size of N= 2,920 showed a diverse patient population by gender, age, 
illness, race and socioeconomic status representing eight counties surrounding the Macon 
area.  
 Research Question #1: Descriptive analysis of data pertaining to code status 
demonstrated that the change to no code status/DNR was over 50% higher than the 
change from no code to full code.  Data reflected the significance of change for both 
gender variables, both race categories of Black and White, in both age categories, and for 
both cancer and non-cancer patients. Data further reflected this significant shift from full 
code to no code in some categories of education and income in both categories of the 
insured and the underinsured indicating changes in levels of socioeconomic status. 
Further investigation of the code status changes presented data that suggested that 
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younger people are more likely to stay full code than DNR when everything else is equal. 
Multivariate analysis also demonstrated that Blacks have higher odds of full code status 
than Whites. It was somewhat surprising that when socioeconomic status was factored 
into the multivariate analysis, it did not seem to affect the outcome with any significance.  
 Research Question #2: Descriptive analysis of data pertaining to comfort and 
aggressive measures showed close to a 40% higher rate of change from aggressive to 
comfort measures only, than from comfort to aggressive measures following the 
intervention for the total population. This is a surprisingly high change from aggressive to 
comfort because comfort measures was defined as no treatment, only pain measures and 
did not include those who shifted from for example Status I to Status III defined above. 
Only Status IV patients were measured as comfort. Therefore, de-escalation may have 
been present but not included in the data set. The measurement was used to represent 
those who decided to remove all therapeutic curative measures.  
Significant results consistent with this total population outcome were seen in 
variables of gender, both female and male, in both categories of race and age, and in both 
cancer and non-cancer patients. Not all categories of education and income could be 
computed, but for those that could, significant changes consistent with this same outcome 
were found. With respect to socioeconomic status, the payer source variable measure 
showed change from aggressive to comfort measures at almost 40% for both the insured 
and underinsured.  
 Further investigation of the interaction between socioeconomic status and race in 
change of care levels using a multivariate analysis concluded that Blacks with an 
education level less than high school had 54% higher chance likelihood of using 
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aggressive measures at the end of life than Whites with the same education level when all 
else was equal and patients were receiving aggressive care prior to the intervention. This 
is consistent with the literature cited in this study. 
 Research Question #3: In an examination of the factors as they may relate to a 
hospice discharge, there were significant differences in hospice use based on race and 
socioeconomic status. Overall, Whites were over 10% more likely to use hospice services 
than Blacks. Those with lower income were less likely to use hospice services. There was 
a greater than 10% difference in “no hospice” results from the lowest income category to 
those making the highest income. Surprisingly, there was no significant difference in use 
of hospice according to payer source. Those patients with an education level less than 
high school had a higher percentage of “no hospice” than those with more education. Not 
surprisingly, a higher number of cancer patients used hospice than those without cancer, a 
close to 30% difference. The original use for hospice services was for cancer patients 
alone, so this may support a historical trend (Stevenson & Bramson, 2009).  
 Research Question #4: In examining cost per length of stay, a multivariate 
analysis was not included. However, for total population there was an overall decrease in 
length of stay following a palliative intervention. The highest percentage decrease was in 
those patients with >21 days, who showed over 5% decrease in length of stay. 
 Research Question #5: In examining cost per days saved, the overall mean 
average days saved was 3.68 per patient following the palliative intervention. There was 
a significant difference in days saved within variables of age, disease and use of hospice 
discharge. Those who utilized hospice after discharge or in the hospital saved 1-2 days of 
acute hospital care at the end of life.   
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 To summarize the findings, the palliative intervention proved to align with the 
literature in respect to racial differences in choices of care. Blacks used aggressive, non-
hospice care more of the time than Whites. When looking at the interaction between race 
and socioeconomic status, the most significant difference is seen in Blacks and Whites 
with less than high school education where Blacks choose aggressive measures over 50% 
of the time more often. Further, this study’s findings showed that variables including 
disease, age and socioeconomic status may factor into end of life decision making, but all 
are impacted by the palliative intervention.  
Conclusions 
From this study, the following conclusions are made: 
• Palliative care does make an overall impact on the use of full code status and 
aggressive care measures. The intervention does result in the de-escalation of care 
for a significant number of patients (Research Questions #1,2). 
• America is very evidently, a society rooted in autonomy, and that applies to 
healthcare at end of life in the surveyed region. Income, race, and education did not 
deny the patient the ability to make an individual and diverse choice about what 
treatments they would choose though these variables likely shaped that decision 
(Research Questions #1,2,3).  
• This study adds to the literature on the positive effects of a palliative care program 
in a hospital (Research Questions #1,2,4,5). 
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• Despite increasing use of aggressive hospital technology at the end of life, 
withholding and withdrawing care are also increasingly common (Research 
Question #2). 
• Though Georgia has a grade “D” rank on their palliative programs (Goldsmith, 
Dietrich, Qingling, Morrison, 2008), the Medical Center of Central Georgia has a 
program achieving significant results. (Research Questions #1, 2,3,4,5)    
• Blacks utilize aggressive non-hospice care more of the time than Whites (Research 
Questions #2,3). 
• Specific to the interaction between socioeconomic status and race with regard to 
change in care levels, Blacks with less than high school education have a greater 
than 50% chance of aggressive care than Whites with the same SES. 
• Socioeconomic status appears to impact the use of hospice (Research Question #3). 
• Cancer patients appear to utilize hospice more of the time than non-cancer patients 
(Research Question #3).  
• This study adds to the literature on healthcare cost reductions, showing that 
palliative care interventions do result in resource savings through the decreased 
length of stay, costs per day and days saved measurement tools (Research 
Questions #4,5). 
• Even after all information is given to a patient and family through the conference 
and clinical intervention, some may still favor a death on artificial support as their 
autonomous choice representing their values for quality of end of life (Research 
Questions #s 1,2,3). 
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Discussion of Findings 
 Researchers have argued that heightened technology has become so effective at 
extending life that it has become more difficult to recognize what defines end of life 
(Reynolds et al., 2005). Some researchers argue this is attributable to our U.S. culture, 
while others postulate that effective advancements in medical technology inhibit the 
ability to grasp prognosis (Glass, 2008; Reynolds, Cooper, & McKneally, 2005). A 
person’s end of life may be wrought with tests, treatments, hospitalizations, resuscitations 
and artificial support, or it may be without all medical means including Cardio 
Pulmonary Resuscitation and removed from the hospital realm entirely. This remains true 
with this research population. Each patient experienced a unique end of life, dependent 
upon many factors.  
End-of-life care practices are shaped by a person’s heritage, surroundings, 
religion and family. They are culturally centered. (University of Washington Medical 
Center, 2007). The significant differences revealed in this study show that treatment level 
decisions at end of life are unique to the patient and may change based upon the palliative 
intervention, family conference and dynamics addressed by healthcare professionals.  
Dying patients value symptom management and good relationships with their 
physicians.  Communication between patient and doctor about prognosis and goals of 
care directly impact the quality of a patient’s end-of-life experience (Biola, Sloane, 
Williams, Daalman, Williams, Zimmerman, 2007).  The findings in this study show that 
patients may be impacted to de-escalate their care when a lengthy conference and 
attention to symptom and pain management is shown through the palliative intervention. 
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The findings in this study align with the body of literature with respect to racial 
inconsistencies with end-of-life care. This study attempted to confirm or disprove those 
documented differences following this unique intervention, and ultimately showed that a 
palliative intervention is beneficial in both race categories but the differential in Blacks 
favoring more aggressive care, remains.  
Findings consistent with variables within the realm of socioeconomic status 
demonstrate the potential weaknesses of a patient centered approach in hospital care. 
Socioeconomic information is not a part of the medical record. Only address and payer 
source offers some glimpse at socioeconomic background. Without income and education 
information, it may become difficult for healthcare professionals to address barriers of a 
socioeconomic nature. For example, literacy issues and poverty can only be assumed, not 
known.  
Findings specific to hospice care demonstrate the continued resistance towards 
hospice dependent on race, disease, education and income. Consistent with the literature, 
the underutilization of hospice by all groups is documented. Though this quantitative 
research does not suggest why the underuse, predictor variables do give some 
examination of characteristics which may impact the decision.  
Healthcare is expensive. Several studies document the cost savings and decrease 
in lengths of stay which result from palliative care in the hospital (Bendaly, Groves, 
Juliar, Gramelspacher, 2008).  This study adds to that body of literature and findings 
suggest that hospital costs are saved through lower length of stay after the intervention 
has taken place. This study’s cost findings show the profound impact on days saved and 
lowered length of stay without dependence on any one variable. Overall, length of stay 
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was decreased dramatically. The systematic sample demonstrates more dollar specifics 
on the savings as a direct result of the intervention. 
Study Strengths and Limitations 
This study provides researchers, and hospital leadership, practitioners and staff 
with a pre and post examination of the palliative intervention and its impact on code 
status, care levels, hospice use, and cost.  The major strength of the study is the large 
sample of patients  N=2,920 examined over the three year period. It is reasonable to 
conclude that results provide a true representation of patient population. The high number 
of patients provides a valuable snapshot of diversity in age, race, geographic residence, 
education level, income and disease. As the medical realm is ever-changing, looking at a 
three year time period helped to show consistency of services within the intervention.  
A second strength of this study is the focus on palliative care conducted in 
Georgia. This focus not only adds to the literature where it is lacking but also 
demonstrates the positive impact of a high-volume program in a Georgia hospital serving 
both rural and urban patients. It is also reasonable to make the claim that the study argues 
against the low rank on palliative care in this region. 
Seen as a third strength, this study highlights an understated public health concern 
that is the end of life. This includes end-of-life care, disparities and inconsistencies 
between races and amongst socioeconomic status in end-of-life treatment choices, 
enhanced quality of life at the end and high end-of-life costs. More specifically, it is 
reasonable to conclude that the ability to have a meaningful discussion at end of life and 
to address symptom management offered through the palliative intervention, impacts care 
level choices and healthcare resources.   
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As a fourth and final strength of this study, the focus on both racial and 
socioeconomic variables at the end of life demonstrated the complexity of these 
decisions, reasonably concluding that one variable alone may not predict an outcome. 
There are limited white papers on the racial differences, while published data on 
socioeconomic status impacts are lacking. Therefore, this study expanded the literature 
specific to variables of geographic measurements, income, education level and race to 
predict treatment choices.   
As with any study, this research was not without limitations. A major limitation of 
this study was the sole use of data from MCCG, including the medical record and a 
subsequent footprints data source to define variables. Both the medical record data and 
footprints data are entered by staff at MCCG.  It is possible that measurement bias may 
have affected some of the data through basic human error. Further, socioeconomic status 
variables of income and education were not available through the medical record, and 
therefore geocoding had to be used.   
The geocoding process to define socioeconomic variables created a possible 
limitation. The study was limited to using only addresses that would match a census tract. 
This excluded patients without a correct street address and those with nursing home or 
outlying facility addresses. Further, when population based data is gathered by the 
government, to protect confidentiality, household information is not representative of that 
one person, but rather the majority in the tract. Individual income and education level 
cannot be accessed as public information. The census bureau provides averages for the 
given area and the individual patient information must be inferred. This provides a 
margin of error and a possible limitation.  
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Implications for Public Health 
This study provides insight into three major areas of public health- enhanced 
quality of life, racial and socioeconomic disparities, and resource savings in healthcare. 
Quality of life or quality of death, for the purpose of this study is an area that remains 
difficult to define. The right-to-die movements highlighted concepts of dignity at the end 
of life, prolonged deaths and the individual costs associated with life-sustaining 
technologies (Knaus et al., 1995). What can be concluded from this study specific to the 
quality of death measurement is that a patient’s care level choices are personal. For some 
patients, death on artificial support is the appropriate choice while for others a death 
without aggressive treatments is one that defines quality. 
Few studies address racial disparities specific to the end of life (Muni et al., 
2011). Likewise, even fewer studies address socioeconomic status as a confounder to 
racial differences in care choice (Muni et al., 2011). The current research addressed both 
areas of disparity in public health. This study’s conclusions show increased use of 
resources by minorities and those with a lower socioeconomic status, which is 
inconsistent with most disparity research on primary and secondary interventions.  This 
finding is significant to the potential development of any public health education that 
might be implemented on end-of-life care. Access to life-sustaining interventions at the 
end of life is not shown to be an issue, but rather possible uninformed decisions for 
potential over-use of the interventions.  
The economics of death, including high healthcare costs at the end of life, are well 
documented (Zhang et al., 2009).  Historical trends for end-of-life spending document the 
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particularly high costs associated with care in the last year of life (Emanuel & Emanuel, 
1994; Luce & Rubenfield, 2002). Perhaps the most significant contribution of this study 
is the evidence of cost savings through the use of a palliative program, aimed at providing 
better clinical symptom management and heightened communication services for 
terminal patients. In a healthcare reform era, the examination of an area which proved to 
reduce healthcare costs has great implications on public health.  
Finally, and more specific to public health in Georgia, is the evidence of a 
regional facility’s impact on a nationally under-ranked area of medicine. In a recent 
survey of hospital based palliative programs, Georgia is ranked on the lower end of 
average, with 20% to 40% of hospitals recorded as having programs (Goldsmith et al., 
2008).   While many hospitals in Georgia may continue to operate without a program, it 
is noteworthy to highlight the success of this program and its impact on Georgia patients 
in both rural and urban areas.  
Suggestions for Future Research 
The palliative intervention is clearly both a quantitative and a qualitative effort. 
This study only used the quantitative data from pre and post interventions As a follow-up, 
a qualitative study looking more closely at the intervention, and focused on geared  
interdisciplinary efforts and communication, might be worthy of pursuit. The qualitative 
analysis might include interviews with the counselors who conduct the family conference 
and practitioners who provide assessment and clinical orders for symptom management. 
This would add to the content and understanding of this study’s purpose.  
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A worthy area of focus might also include utilization of active patient subjects for 
qualitative review of the intervention and for a closer relationship with data. This would 
also allow the researcher to define socioeconomic status based on the patient’s self-
evaluation and to glean some more in-depth understanding surrounding why treatment 
decisions are made. Further areas of focus might include, a more specific analysis of 
status changes from I to II and II to III to define specific de-escalation of care, a more in-
depth categorization of primary disease condition to improve understanding of the 
complexities of the patient’s illness, and an expansion of race categories to include other 
minority patients like Hispanic and Asian. Further, a worthy study may focus on other 
hospitals in the area to help and expand understanding of the palliative intervention and 
its regional impact.    
Finally, palliative care is a young area, and further investigation is needed to 
better this study, and future studies are recommended. 
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